| Year |
Citation |
Score |
| 2023 |
Timmins IR, Jones ME, O'Brien KM, Adami HO, Aune D, Baglietto L, Bertrand KA, Brantley KD, Chen Y, Clague DeHart J, Clendenen TV, Dossus L, Eliassen AH, Fletcher O, Fournier A, ... ... Visvanathan K, et al. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2301101. PMID 38079601 DOI: 10.1200/JCO.23.01101 |
0.701 |
|
| 2023 |
Daly MB, Pal T, Maxwell KN, Churpek J, Kohlmann W, AlHilli Z, Arun B, Buys SS, Cheng H, Domchek SM, Friedman S, Giri V, Goggins M, Hagemann A, Hendrix A, ... ... Visvanathan K, et al. NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024. Journal of the National Comprehensive Cancer Network : Jnccn. 21: 1000-1010. PMID 37856201 DOI: 10.6004/jnccn.2023.0051 |
0.456 |
|
| 2023 |
Rudolph JE, Calkins K, Xu X, Wentz E, Pirsl F, Visvanathan K, Lau B, Joshu C. Comparing cancer incidence in an observational cohort of Medicaid beneficiaries with and without HIV, 2001-2015. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 37831615 DOI: 10.1097/QAI.0000000000003318 |
0.335 |
|
| 2023 |
Bouras E, Kim AE, Lin Y, Morrison J, Du M, Albanes D, Barry EL, Baurley JW, Berndt SI, Bien SA, Bishop TD, Brenner H, Budiarto A, Burnett-Hartman A, Campbell PT, ... ... Visvanathan K, et al. Genome-wide interaction analysis of folate for colorectal cancer risk. The American Journal of Clinical Nutrition. PMID 37640106 DOI: 10.1016/j.ajcnut.2023.08.010 |
0.314 |
|
| 2023 |
Wu Z, Petrick JL, Florio AA, Guillemette C, Beane Freeman LE, Buring JE, Bradwin G, Caron P, Chen Y, Eliassen AH, Engel LS, Freedman ND, Gaziano JM, Giovannuci EL, Hofmann JN, ... ... Visvanathan K, et al. Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the Liver Cancer Pooling Project. Jhep Reports : Innovation in Hepatology. 5: 100742. PMID 37425211 DOI: 10.1016/j.jhepr.2023.100742 |
0.336 |
|
| 2023 |
Uhelski AR, Blackford AL, Sheng JY, Snyder C, Lehman J, Visvanathan K, Lim D, Stearns V, Smith KL. Factors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer. Journal of Cancer Survivorship : Research and Practice. PMID 37261654 DOI: 10.1007/s11764-023-01408-y |
0.405 |
|
| 2023 |
Kim ES, Scharpf RB, Garcia-Closas M, Visvanathan K, Velculescu VE, Chatterjee N. Potential utility of risk stratification for multicancer screening with liquid biopsy tests. Npj Precision Oncology. 7: 39. PMID 37087533 DOI: 10.1038/s41698-023-00377-w |
0.322 |
|
| 2023 |
Connor AE, Dibble KE, Visvanathan K. Lifestyle factors in Black female breast cancer survivors-Descriptive results from an online pilot study. Frontiers in Public Health. 11: 1072741. PMID 36998282 DOI: 10.3389/fpubh.2023.1072741 |
0.457 |
|
| 2023 |
Ambinder EB, Lee E, Nguyen DL, Gong AJ, Haken OJ, Visvanathan K. Interval Breast Cancers Versus Screen Detected Breast Cancers: A Retrospective Cohort Study. Academic Radiology. PMID 36739227 DOI: 10.1016/j.acra.2023.01.007 |
0.472 |
|
| 2023 |
Papadimitriou N, Bull CJ, Jenab M, Hughes DJ, Bell JA, Sanderson E, Timpson NJ, Smith GD, Albanes D, Campbell PT, Küry S, Le Marchand L, Ulrich CM, Visvanathan K, Figueiredo JC, et al. Separating the effects of early and later life adiposity on colorectal cancer risk: a Mendelian randomization study. Bmc Medicine. 21: 5. PMID 36600297 DOI: 10.1186/s12916-022-02702-9 |
0.34 |
|
| 2023 |
Visvanathan K, Mondul AM, Zeleniuch-Jacquotte A, Wang M, Gail MH, Yaun SS, Weinstein SJ, McCullough ML, Eliassen AH, Cook NR, Agnoli C, Almquist M, Black A, Buring JE, Chen C, et al. Circulating vitamin D and breast cancer risk: an international pooling project of 17 cohorts. European Journal of Epidemiology. PMID 36593337 DOI: 10.1007/s10654-022-00921-1 |
0.413 |
|
| 2022 |
Visvanathan K, Cope L, Fackler MJ, Considine M, Sokoll L, Carey LA, Forero-Torres A, Ingle JN, Lin NU, Nanda R, Storniolo AM, Tulac S, Venkatesan N, Wu NC, Marla S, et al. Evaluation of a Liquid Biopsy-Breast Cancer Methylation (LBx-BCM) Cartridge Assay for Predicting Early Disease Progression and Survival: TBCRC 005 Prospective Trial. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36534524 DOI: 10.1158/1078-0432.CCR-22-2128 |
0.402 |
|
| 2022 |
Deng Z, Jones MR, Wang MC, Wolff AC, Visvanathan K. Racial and ethnic disparities in mortality among breast cancer survivors after a second malignancy. Journal of the National Cancer Institute. PMID 36529890 DOI: 10.1093/jnci/djac220 |
0.439 |
|
| 2022 |
Fackler MJ, Tulac S, Venkatesan N, Aslam AJ, de Guzman TN, Mercado-Rodriguez C, Cope LM, Downs BM, Vali AH, Ding W, Lehman J, Denbow R, Reynolds J, Buckley ME, Visvanathan K, et al. Development of an automated liquid biopsy assay for methylated markers in advanced breast cancer. Cancer Research Communications. 2: 391-401. PMID 36046124 DOI: 10.1158/2767-9764.crc-22-0133 |
0.32 |
|
| 2022 |
Connor AE, Dibble KE, Visvanathan K. Utilizing Social Media Advertisements and Participant Social Networks to Recruit African American Breast Cancer Survivors: Design and Rationale. Frontiers in Public Health. 10: 931102. PMID 35899153 DOI: 10.3389/fpubh.2022.931102 |
0.394 |
|
| 2022 |
Deng Z, Jones MR, Wang MC, Visvanathan K. Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study. Npj Breast Cancer. 8: 82. PMID 35835760 DOI: 10.1038/s41523-022-00447-5 |
0.523 |
|
| 2022 |
Goyal A, Milner GE, Cimino-Mathews A, Visvanathan K, Wolff AC, Sharma D, Sheng JY. Weight Gain after Hormone Receptor-Positive Breast Cancer. Current Oncology (Toronto, Ont.). 29: 4090-4103. PMID 35735435 DOI: 10.3390/curroncol29060326 |
0.405 |
|
| 2022 |
Jordahl KM, Shcherbina A, Kim AE, Su YR, Lin Y, Wang J, Qu C, Albanes D, Arndt V, Baurley JW, Berndt SI, Bien SA, Bishop DT, Bouras E, Brenner H, ... ... Visvanathan K, et al. Beyond GWAS of Colorectal Cancer: Evidence of Interaction with Alcohol Consumption and Putative Causal Variant for the 10q24.2 Region. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. OF1-OF13. PMID 35438744 DOI: 10.1158/1055-9965.EPI-21-1003 |
0.324 |
|
| 2021 |
Walsh EM, Mangini N, Fetting J, Armstrong D, Chan IS, Connolly RM, Fiallos K, Lehman J, Nunes R, Petry D, Reynolds J, Shah M, Smith KL, Visvanathan K, Lauring J, et al. Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes. Clinical Breast Cancer. PMID 35074264 DOI: 10.1016/j.clbc.2021.12.007 |
0.326 |
|
| 2021 |
Karia PS, Tehranifar P, Visvanathan K, Wright JD, Genkinger JM. Cancer-Specific Mortality in Asian American Women Diagnosed with Gynecologic Cancer: A Nationwide Population-Based Analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34933960 DOI: 10.1158/1055-9965.EPI-21-0829 |
0.356 |
|
| 2021 |
Connor AE, Kaur M, Dibble KE, Visvanathan K, Dean LT, Hayes JH. Racialized economic segregation and breast cancer mortality among women in Maryland. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34862211 DOI: 10.1158/1055-9965.EPI-21-0923 |
0.452 |
|
| 2021 |
Kaur M, Joshu CE, Visvanathan K, Connor AE. Trends in breast cancer incidence rates by race/ethnicity: Patterns by stage, socioeconomic position, and geography in the United States, 1999-2017. Cancer. 128: 1015-1023. PMID 34731501 DOI: 10.1002/cncr.34008 |
0.374 |
|
| 2021 |
Ambinder EB, Oluyemi E, Kong X, Nguyen DL, Visvanathan K. Disparities in the uptake of digital breast tomosynthesis for breast cancer screening: A retrospective cohort study. The Breast Journal. 27: 872-876. PMID 34668275 DOI: 10.1111/tbj.14292 |
0.432 |
|
| 2021 |
Townsend MK, Trabert B, Fortner RT, Arslan AA, Buring JE, Carter BD, Giles GG, Irvin SR, Jones ME, Kaaks R, Kirsh VA, Knutsen SF, Koh WP, Lacey JV, Langseth H, ... ... Visvanathan K, et al. Cohort Profile: The Ovarian Cancer Cohort Consortium (OC3). International Journal of Epidemiology. PMID 34652432 DOI: 10.1093/ije/dyab211 |
0.381 |
|
| 2021 |
Karia PS, Joshu CE, Visvanathan K. Uptake and predictors of opportunistic salpingectomy for ovarian cancer risk reduction in the United States. Cancer Prevention Research (Philadelphia, Pa.). PMID 34413116 DOI: 10.1158/1940-6207.CAPR-21-0121 |
0.409 |
|
| 2021 |
Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Bertone-Johnson E, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, ... ... Visvanathan K, et al. Breast cancer risk factors and circulating anti-Müllerian hormone concentration in healthy premenopausal women. The Journal of Clinical Endocrinology and Metabolism. PMID 34157104 DOI: 10.1210/clinem/dgab461 |
0.701 |
|
| 2021 |
Wu Y, Huang R, Wang M, Bernstein L, Bethea TN, Chen C, Chen Y, Eliassen AH, Freedman ND, Gaudet MM, Gierach GL, Giles GG, Krogh V, Larsson SC, Liao LM, ... ... Visvanathan K, et al. Dairy foods, calcium, and risk of breast cancer overall and for subtypes defined by estrogen receptor status: a pooled analysis of 21 cohort studies. The American Journal of Clinical Nutrition. PMID 33964859 DOI: 10.1093/ajcn/nqab097 |
0.401 |
|
| 2021 |
Connor AE, Schmaltz CL, Jackson-Thompson J, Visvanathan K. Comorbidities and the risk of cardiovascular disease mortality among racially diverse patients with breast cancer. Cancer. PMID 33793967 DOI: 10.1002/cncr.33530 |
0.479 |
|
| 2021 |
Tsilidis KK, Papadimitriou N, Dimou N, Gill D, Lewis SJ, Martin RM, Murphy N, Markozannes G, Zuber V, Cross AJ, Burrows K, Lopez DS, Key TJ, Travis RC, Perez-Cornago A, ... ... Visvanathan K, et al. Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: a Mendelian randomization study. The American Journal of Clinical Nutrition. PMID 33740060 DOI: 10.1093/ajcn/nqab003 |
0.331 |
|
| 2021 |
Coburn SB, Shiels M, Silverberg M, Horberg M, Gill MJ, Brown TT, Visvanathan K, Connor AE, Napravnik S, Marcus J, Moore RD, Mathews WC, Mayor AM, Sterling T, Li J, et al. Secular Trends in Breast Cancer Risk among Women with HIV Initiating ART in North America. Journal of Acquired Immune Deficiency Syndromes (1999). PMID 33492023 DOI: 10.1097/QAI.0000000000002627 |
0.436 |
|
| 2021 |
Ter-Minassian M, Schaeffer ML, Jefferson CR, Shapiro SC, Suwannarat P, Visvanathan K. Screening and Preventative Strategies for Patients at High Risk for Breast Cancer. Jco Oncology Practice. OP2000262. PMID 33428469 DOI: 10.1200/OP.20.00262 |
0.467 |
|
| 2021 |
Daly MB, Pal T, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Goggins M, Hutton ML, Karlan BY, Khan S, Klein C, Kohlmann W, ... ... Visvanathan K, et al. Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network : Jnccn. 19: 77-102. PMID 33406487 DOI: 10.6004/jnccn.2021.0001 |
0.491 |
|
| 2020 |
Cao Y, Baumgartner KB, Visvanathan K, Boone SD, Baumgartner RN, Connor AE. Ethnic and biological differences in the association between physical activity and survival after breast cancer. Npj Breast Cancer. 6: 51. PMID 34625568 DOI: 10.1038/s41523-020-00194-5 |
0.49 |
|
| 2020 |
Fackler MJ, Cho S, Cope L, Gabrielson E, Visvanathan K, Wilsbach K, Meir-Levi D, Lynch CF, Marks J, Geradts J, Regan MM, Viale G, Wolff AC, Sukumar S, Umbricht CB. DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. Npj Breast Cancer. 6: 3. PMID 33514703 DOI: 10.1038/s41523-020-0145-3 |
0.327 |
|
| 2020 |
Bull CJ, Bell JA, Murphy N, Sanderson E, Davey Smith G, Timpson NJ, Banbury BL, Albanes D, Berndt SI, Bézieau S, Bishop DT, Brenner H, Buchanan DD, Burnett-Hartman A, Casey G, ... ... Visvanathan K, et al. Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study. Bmc Medicine. 18: 396. PMID 33327948 DOI: 10.1186/s12916-020-01855-9 |
0.313 |
|
| 2020 |
Xie E, Lapinski MM, Talamantes S, Nonyane BAS, Magalhães MCF, Visvanathan K, Wolff AC, Santa-Maria CA. Relationship of circulating immune cells with lifestyle factors and cancer recurrence in early-stage breast cancer. Breast Cancer Research and Treatment. PMID 33185832 DOI: 10.1007/s10549-020-06016-3 |
0.393 |
|
| 2020 |
van den Brandt PA, Ziegler RG, Wang M, Hou T, Li R, Adami HO, Agnoli C, Bernstein L, Buring JE, Chen Y, Connor AE, Eliassen AH, Genkinger JM, Gierach G, Giles GG, ... ... Visvanathan K, et al. Body size and weight change over adulthood and risk of breast cancer by menopausal and hormone receptor status: a pooled analysis of 20 prospective cohort studies. European Journal of Epidemiology. PMID 33128203 DOI: 10.1007/s10654-020-00688-3 |
0.34 |
|
| 2020 |
Cao Y, Baumgartner KB, Visvanathan K, Boone SD, Baumgartner RN, Connor AE. Ethnic and biological differences in the association between physical activity and survival after breast cancer. Npj Breast Cancer. 6: 51. PMID 33083530 DOI: 10.1038/s41523-020-00194-5 |
0.488 |
|
| 2020 |
Santala EEE, Murto MO, Artama M, Pukkala E, Visvanathan K, Murtola TJ. Angiotensin Receptor Blockers Associated with Improved Breast Cancer Survival-A Nationwide Cohort Study from Finland. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32917663 DOI: 10.1158/1055-9965.Epi-20-0711 |
0.548 |
|
| 2020 |
Thomas M, Sakoda LC, Hoffmeister M, Rosenthal EA, Lee JK, van Duijnhoven FJB, Platz EA, Wu AH, Dampier CH, de la Chapelle A, Wolk A, Joshi AD, Burnett-Hartman A, Gsur A, Lindblom A, ... ... Visvanathan K, et al. Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk. American Journal of Human Genetics. PMID 32758450 DOI: 10.1016/J.Ajhg.2020.07.006 |
0.365 |
|
| 2020 |
Fortner RT, Rice MS, Knutsen SF, Orlich MJ, Visvanathan K, Patel AV, Gaudet MM, Tjonneland A, Kvaskoff M, Kaaks R, Trichopoulou A, Pala V, Onland-Moret NC, Gram IT, Amiano P, et al. Ovarian cancer risk factor associations by primary anatomic site: the Ovarian Cancer Cohort Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32732252 DOI: 10.1158/1055-9965.Epi-20-0354 |
0.488 |
|
| 2020 |
Ramin C, Schaeffer ML, Zheng Z, Connor AE, Hoffman-Bolton J, Lau B, Visvanathan K. All-cause and cardiovascular disease mortality among breast cancer survivors in CLUE II, a long-standing community-based cohort. Journal of the National Cancer Institute. PMID 32634223 DOI: 10.1093/Jnci/Djaa096 |
0.542 |
|
| 2020 |
Sheng JY, Santa-Maria CA, Mangini N, Norman H, Couzi R, Nunes R, Wilkinson M, Visvanathan K, Connolly RM, Roussos Torres ET, Fetting JH, Armstrong DK, Tao JJ, Jacobs L, Wright JL, et al. Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach. Jco Oncology Practice. OP2000364. PMID 32603252 DOI: 10.1200/Op.20.00364 |
0.522 |
|
| 2020 |
Tang H, Jiang L, Stolzenberg-Solomon R, Arslan AA, Beane Freeman LE, Bracci P, Brennan P, Canzian F, Du M, Gallinger S, Giles G, Goodman PJ, Kooperberg C, Le Marchand L, Neale RE, ... ... Visvanathan K, et al. Genome-wide gene-diabetes and gene-obesity interaction scan in 8,255 cases and 11,900 controls from the PanScan and PanC4 Consortia. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32546605 DOI: 10.1158/1055-9965.Epi-20-0275 |
0.312 |
|
| 2020 |
Chao CA, Huang L, Visvanathan K, Mwakatobe K, Masalu N, Rositch AF. Understanding women's perspectives on breast cancer is essential for cancer control: knowledge, risk awareness, and care-seeking in Mwanza, Tanzania. Bmc Public Health. 20: 930. PMID 32539723 DOI: 10.1186/S12889-020-09010-Y |
0.571 |
|
| 2020 |
Zhu J, Shu X, Guo X, Liu D, Bao J, Milne RL, G Giles G, Wu C, Du M, White E, Risch HA, Malats N, Duell EJ, Goodman PJ, Li D, ... ... Visvanathan K, et al. Associations between genetically predicted blood protein biomarkers and pancreatic cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32439797 DOI: 10.1158/1055-9965.Epi-20-0091 |
0.356 |
|
| 2020 |
Daly MB, Pilarski R, Yurgelun MB, Berry MP, Buys SS, Dickson P, Domchek SM, Elkhanany A, Friedman S, Garber JE, Goggins M, Hutton ML, Khan S, Klein C, Kohlmann W, ... ... Visvanathan K, et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020. Journal of the National Comprehensive Cancer Network : Jnccn. 18: 380-391. PMID 32259785 DOI: 10.6004/Jnccn.2020.0017 |
0.514 |
|
| 2020 |
Calkins KL, Chander G, Joshu CE, Visvanathan K, Fojo AT, Lesko CR, Moore RD, Lau B. A comparison of cancer stage at diagnosis and treatment initiation between enrollees in an urban HIV clinic and SEER. Cancer Causes & Control : Ccc. PMID 32144680 DOI: 10.1007/S10552-020-01289-X |
0.35 |
|
| 2020 |
Fackler MJ, Cho S, Cope L, Gabrielson E, Visvanathan K, Wilsbach K, Meir-Levi D, Lynch CF, Marks J, Geradts J, Regan MM, Viale G, Wolff AC, Sukumar S, Umbricht CB. DNA methylation markers predict recurrence-free interval in triple-negative breast cancer. Npj Breast Cancer. 6: 3. PMID 32025567 DOI: 10.1038/s41523-020-0145-3 |
0.324 |
|
| 2020 |
Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Chen Y, Connor AE, Dossus L, Eliassen AH, ... ... Visvanathan K, et al. Adult weight change and premenopausal breast cancer risk: A prospective pooled analysis of data from 628,463 women. International Journal of Cancer. PMID 32012248 DOI: 10.1002/Ijc.32892 |
0.72 |
|
| 2020 |
Trabert B, Tworoger SS, O'Brien KM, Townsend MK, Fortner RT, Iversen ES, Hartge P, White E, Amiano P, Arslan AA, Bernstein L, Brinton LA, Buring JE, Dossus L, Fraser GE, ... ... Visvanathan K, et al. The risk of ovarian cancer increases with an increase in the lifetime number of ovulatory cycles: an analysis from the Ovarian Cancer Cohort Consortium (OC3). Cancer Research. PMID 31932455 DOI: 10.1158/0008-5472.Can-19-2850 |
0.521 |
|
| 2020 |
Zhong J, Jermusyk A, Wu L, Hoskins JW, Collins I, Mocci E, Zhang M, Song L, Chung CC, Zhang T, Xiao W, Albanes D, Andreotti G, Arslan AA, Babic A, ... ... Visvanathan K, et al. A Transcriptome-Wide Association Study (TWAS) Identifies Novel Candidate Susceptibility Genes for Pancreatic Cancer. Journal of the National Cancer Institute. PMID 31917448 DOI: 10.1093/Jnci/Djz246 |
0.387 |
|
| 2020 |
Genkinger JM, Wu K, Wang M, Albanes D, Black A, van den Brandt PA, Burke KA, Cook MB, Gapstur SM, Giles GG, Giovannucci E, Goodman GG, Goodman PJ, Håkansson N, Key TJ, ... ... Visvanathan K, et al. Measures of body fatness and height in early and mid-to-late adulthood and prostate cancer: risk and mortality in The Pooling Project of Prospective Studies of Diet and Cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 31: 103-114. PMID 31912782 DOI: 10.1016/J.Annonc.2019.09.007 |
0.315 |
|
| 2020 |
Karia PS, Joshu CE, Rosenshein NB, Visvanathan K. Adoption of opportunistic salpingectomy for ovarian cancer prevention: Results from a nationwide sample of privately insured women. Journal of Clinical Oncology. 38: 1561-1561. DOI: 10.1200/Jco.2020.38.15_Suppl.1561 |
0.478 |
|
| 2020 |
Connor AE, May B, Schmaltz C, Jackson-Thompson J, Visvanathan K. Abstract B120: Hospitalization may be an early indicator of worse breast cancer survival among women from disparate populations Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp19-B120 |
0.491 |
|
| 2020 |
Connor AE, Visvanathan K, Boone SD, Baumgartner KB, Baumgartner RN. Abstract C077: The association between diabetes, plasma fructosamine, and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white women Cancer Epidemiology, Biomarkers & Prevention. DOI: 10.1158/1538-7755.Disp18-C077 |
0.505 |
|
| 2020 |
Xie EG, Lapinski MM, Talamantes S, Visvanathan K, Wolff A, Santa-Maria C. Abstract P5-04-16: Association of circulating immune cells with lifestyle factors, and recurrence and mortality in patients with early stage breast cancer Cancer Research. DOI: 10.1158/1538-7445.Sabcs19-P5-04-16 |
0.473 |
|
| 2020 |
Visvanathan K, Modur S, Artama M, Murtola T. Abstract 5782: Lipophilic Statins show promise for treatment of epithelial ovarian cancer Epidemiology. DOI: 10.1158/1538-7445.Am2020-5782 |
0.429 |
|
| 2020 |
Reiter-Brennan C, Dzaye O, Al-Mallah MH, Dardari Z, Brawner CA, Lamerato LE, Keteyian SJ, Ehrman JK, Visvanathan K, Blaha MJ, Marshall CH. Abstract 5773: Cardiorespiratory fitness and PSA screening patterns in the Henry Ford FIT Project Epidemiology. 80: 5773-5773. DOI: 10.1158/1538-7445.Am2020-5773 |
0.391 |
|
| 2020 |
Reiter-Brennan C, Dzaye O, Al-Mallah MH, Dardari Z, Brawner CA, Lamerato LE, Keteyian SJ, Ehrman JK, Visvanathan K, Blaha MJ, Marshall CH. Abstract 4348: Cardiorespiratory fitness levels in men who develop prostate cancer and its association with all-cause mortality Cancer Research. 80: 4348-4348. DOI: 10.1158/1538-7445.Am2020-4348 |
0.435 |
|
| 2020 |
Karia PS, Joshu CE, Visvanathan K. Abstract 2314: Prevalence and risk factors for occult tubal and ovarian cancer at the time of benign gynecologic surgery in the general population: A nationwide analysis of privately insured women Cancer Research. 80: 2314-2314. DOI: 10.1158/1538-7445.Am2020-2314 |
0.547 |
|
| 2020 |
Butt J, Blot W, Visvanathan K, Le Marchand L, Chen Y, Sesso H, Wassertheil-Smoller S, Ho G, Tinker L, Potter J, Song M, Berndt S, Waterboer T, Pawlita M, Epplein M. Auto-antibodies to p53 and the Subsequent Development of Colorectal Cancer in a United States Prospective Cohort Consortium Cancer Epidemiology Biomarkers & Prevention. 29: 690.1-690. DOI: 10.1158/1055-9965.Epi-20-0050 |
0.383 |
|
| 2019 |
Murphy N, Carreras-Torres R, Song M, Chan AT, Martin RM, Papadimitriou N, Dimou N, Tsilidis KK, Banbury B, Bradbury KE, Besevic J, Rinaldi S, Riboli E, Cross AJ, Travis RC, ... ... Visvanathan K, et al. Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses. Gastroenterology. PMID 31884074 DOI: 10.1053/J.Gastro.2019.12.020 |
0.338 |
|
| 2019 |
Archambault AN, Su YR, Jeon J, Thomas M, Lin Y, Conti DV, Win AK, Sakoda LC, Lansdorp-Vogelaar I, Peterse EF, Zauber AG, Duggan D, Holowatyj AN, Huyghe JR, Brenner H, ... ... Visvanathan K, et al. Cumulative Burden of Colorectal Cancer-Associated Genetic Variants is More Strongly Associated With Early-onset vs Late-onset Cancer. Gastroenterology. PMID 31866242 DOI: 10.1053/J.Gastro.2019.12.012 |
0.441 |
|
| 2019 |
Teras LR, Patel AV, Wang M, Yaun SS, Anderson K, Brathwaite R, Caan BJ, Chen Y, Connor AE, Eliassen AH, Gapstur SM, Gaudet MM, Genkinger JM, Giles GG, Lee IM, ... ... Visvanathan K, et al. Sustained weight loss and risk of breast cancer in women ≥50 years: a pooled analysis of prospective data. Journal of the National Cancer Institute. PMID 31845728 DOI: 10.1093/Jnci/Djz226 |
0.522 |
|
| 2019 |
Sheng JY, Visvanathan K, Thorner E, Wolff AC. Breast cancer survivorship care beyond local and systemic therapy. Breast (Edinburgh, Scotland). 48: S103-S109. PMID 31839149 DOI: 10.1016/S0960-9776(19)31135-X |
0.428 |
|
| 2019 |
Calkins KL, Chander G, Joshu CE, Visvanathan K, Fojo AT, Lesko CR, Moore RD, Lau B. Immune Status and Associated Mortality After Cancer Treatment Among Individuals With HIV in the Antiretroviral Therapy Era. Jama Oncology. PMID 31804663 DOI: 10.1001/Jamaoncol.2019.4648 |
0.381 |
|
| 2019 |
Calkins K, Chander G, Joshu C, Visvanathan K, Fojo AT, Lesko C, Moore R, Lau B. Differences in five year survival after cancer diagnosis between HIV clinic enrollees and the general US population. Aids Research and Human Retroviruses. PMID 31679394 DOI: 10.1089/Aid.2019.0145 |
0.386 |
|
| 2019 |
Kinnunen PT, Murto MO, Artama M, Pukkala E, Visvanathan K, Murtola TJ. Anticoagulants and breast cancer survival, a nationwide cohort study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 31653681 DOI: 10.1158/1055-9965.Epi-19-0147 |
0.531 |
|
| 2019 |
Fabian CJ, Visvanathan K, Somerfield MR. Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update Summary. Journal of Oncology Practice. JOP1900379. PMID 31479308 DOI: 10.1200/Jop.19.00379 |
0.501 |
|
| 2019 |
Visvanathan K, Fabian CJ, Bantug E, Brewster AM, Davidson NE, DeCensi A, Floyd JD, Garber JE, Hofstatter EW, Khan SA, Katapodi MC, Pruthi S, Raab R, Runowicz CD, Somerfield MR. Use of Endocrine Therapy for Breast Cancer Risk Reduction: ASCO Clinical Practice Guideline Update. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1901472. PMID 31479306 DOI: 10.1200/Jco.19.01472 |
0.541 |
|
| 2019 |
Peres LC, Mallen AR, Townsend MK, Poole EM, Trabert B, Allen NE, Arslan AA, Dossus L, Fortner RT, Gram IT, Hartge P, Idahl A, Kaaks R, Kvaskoff M, Magiocco A, ... ... Visvanathan K, et al. High levels of C-reactive protein are associated with an increased risk of ovarian cancer: Results from the Ovarian Cancer Cohort Consortium. Cancer Research. PMID 31462430 DOI: 10.1158/0008-5472.Can-19-1554 |
0.501 |
|
| 2019 |
Dean LT, Ransome Y, Frasso-Jaramillo L, Moss SL, Zhang Y, Ashing K, Denis GV, Frick KD, Visvanathan K, Schmitz KH. Drivers of cost differences between US breast cancer survivors with or without lymphedema. Journal of Cancer Survivorship : Research and Practice. PMID 31446591 DOI: 10.1007/S11764-019-00799-1 |
0.52 |
|
| 2019 |
Downs B, Mercado-Rodriguez C, Cimino-Mathews A, Chen C, Yuan J, Van Den Berg EJ, Cope L, Schmitt F, Tse GM, Ali SZ, Meir-Levi D, Sood R, Li J, Richardson AL, Mosunjac M, ... ... Visvanathan K, et al. DNA Methylation Markers for Breast Cancer Detection in the Developing World. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31300453 DOI: 10.1158/1078-0432.Ccr-18-3277 |
0.513 |
|
| 2019 |
Huang JY, Larose TL, Luu HN, Wang R, Fanidi A, Alcala K, Stevens VL, Weinstein SJ, Albanes D, Caporaso NE, Purdue MP, Ziegler RG, Freedman ND, Lan Q, Prentice RL, ... ... Visvanathan K, et al. Circulating markers of cellular immune activation in pre-diagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). International Journal of Cancer. PMID 31276202 DOI: 10.1002/Ijc.32555 |
0.416 |
|
| 2019 |
Marshall CH, Al-Mallah MH, Dardari Z, Brawner CA, Lamerato LE, Keteyian SJ, Ehrman JK, Visvanathan K, Blaha MJ. Cardiorespiratory fitness and incident lung and colorectal cancer in men and women: Results from the Henry Ford Exercise Testing (FIT) cohort. Cancer. PMID 31056756 DOI: 10.1002/Cncr.32085 |
0.395 |
|
| 2019 |
Clendenen TV, Ge W, Koenig KL, Afanasyeva Y, Agnoli C, Brinton LA, Darvishian F, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, ... ... Visvanathan K, et al. Breast cancer risk prediction in women aged 35-50 years: impact of including sex hormone concentrations in the Gail model. Breast Cancer Research : Bcr. 21: 42. PMID 30890167 DOI: 10.1186/S13058-019-1126-Z |
0.713 |
|
| 2019 |
Zuo H, Ueland PM, Midttun Ø, Tell GS, Fanidi A, Zheng W, Shu X, Xiang Y, Wu J, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, ... ... Visvanathan K, et al. Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3). Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30698666 DOI: 10.1093/Annonc/Mdz002 |
0.415 |
|
| 2019 |
Connor AE, Visvanathan K, Boone SD, Rifai N, Baumgartner KB, Baumgartner RN. Fructosamine and diabetes as predictors of mortality among Hispanic and non-Hispanic white breast cancer survivors. Npj Breast Cancer. 5: 3. PMID 30675513 DOI: 10.1038/s41523-018-0099-x |
0.314 |
|
| 2019 |
Muller DC, Larose TL, Hodge A, Guida F, Langhammer A, Grankvist K, Meyer K, Cai Q, Arslan AA, Zeleniuch-Jacquotte A, Albanes D, Giles GG, Sesso HD, Lee IM, Gaziano JM, ... ... Visvanathan K, et al. Circulating high sensitivity C reactive protein concentrations and risk of lung cancer: nested case-control study within Lung Cancer Cohort Consortium. Bmj (Clinical Research Ed.). 364: k4981. PMID 30606716 DOI: 10.1136/Bmj.K4981 |
0.395 |
|
| 2019 |
Klepin HD, Garrett-Mayer E, Kaltenbaugh M, Bruinooge SS, Rubinstein WS, Meersman SC, Miller RS, Lyman GH, Gray SW, Nekhlyudov L, Osterman TJ, Thota R, Tsimberidou AM, Visvanathan K, Schilsky RL, et al. Hypertension and use of bevacizumab among patients treated in community settings. Journal of Clinical Oncology. 37: e18279-e18279. DOI: 10.1200/Jco.2019.37.15_Suppl.E18279 |
0.301 |
|
| 2019 |
Karia PS, Joshu C, Visvanathan K. Adverse effects of early bilateral oophorectomy on body composition: Results from a nationally representative sample of United States women. Journal of Clinical Oncology. 37: 1568-1568. DOI: 10.1200/Jco.2019.37.15_Suppl.1568 |
0.363 |
|
| 2019 |
Schaeffer ML, May BJ, Hogan BC, Orellana MM, McCullough MC, Armstrong DK, Myers K, Visvanathan K. Breast cancer screening adherence at multiple timepoints over eight years among women in a familial cohort. Journal of Clinical Oncology. 37: 1557-1557. DOI: 10.1200/Jco.2019.37.15_Suppl.1557 |
0.543 |
|
| 2019 |
Rositch A, Ginsburg O, Huang L, Chao C, Visvanathan K, Masalu N. Abstract P5-13-02: Not presented Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P5-13-02 |
0.438 |
|
| 2019 |
Smith K, Griffin J, Tsai H, Leathers M, Hays A, Lu D, Zhang Z, Rosner G, Russell S, Connolly R, Jelovac D, Visvanathan K, Wolff A, Stearns V, Abraham T. Abstract P4-16-09: Effect of simvastatin on cardiac strain in breast cancer patients receiving anthracycline therapy Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-16-09 |
0.391 |
|
| 2019 |
Schaeffer M, May B, Cimino-Mathews A, Orellana M, McCullough M, Hogan B, Armstrong D, Visvanathan K. Abstract P4-10-06: Factors impacting the accuracy of self-reported breast procedures among women with and without breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-10-06 |
0.486 |
|
| 2019 |
Karia P, Joshu C, Visvanathan K. Abstract P4-10-01: Association of bilateral oophorectomy with sarcopenia and sarcopenic obesity in a diverse, nationally representative sample of U.S. women Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P4-10-01 |
0.44 |
|
| 2019 |
Gross A, Blot W, Visvanathan K. Abstract P1-10-02: Type II diabetes and subtype-specific breast cancer risk in medically underserved black and white women Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P1-10-02 |
0.502 |
|
| 2019 |
Connor A, May B, Schmaltz C, Jackson-Thompson J, Visvanathan K. Abstract P1-08-11: The impact of existing comorbidities on survival disparities among women diagnosed with invasive breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P1-08-11 |
0.517 |
|
| 2019 |
Schoemaker M, Nichols H, Wright L, Brook M, Jones M, O'Brien K, Adami H, Baglietto L, Bernstein L, Bertrand K, Boutron-Ruault M, Chen Y, Connor A, Dorronsoro M, Dossus L, ... ... Visvanathan K, et al. Abstract P1-08-01: Withdrawn Cancer Research. DOI: 10.1158/1538-7445.Sabcs18-P1-08-01 |
0.495 |
|
| 2019 |
Rositch A, Chao C, Masalu N, Visvanathan K. Abstract P1-03-09: The breast cancer care continuum in Tanzania: From accessing care for breast concerns to cancer diagnosis and treatment Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P1-03-09 |
0.554 |
|
| 2019 |
Kaur M, Connor AE, Platz EA, Visvanathan K, Joshu CE, Investigators fAC. Abstract 618: A prospective evaluation of waist circumference over time and incidence of postmenopausal breast cancer in the Atherosclerosis Risk in Communities (ARIC) Study Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-618 |
0.538 |
|
| 2019 |
Marshall CH, Dardari Z, Cainzos-Achirica M, Mortensen MB, Nasir K, Al-Mallah MH, Miedema MD, Blankstein R, Blumenthal RS, Visvanathan K, Blaha MJ. Abstract 5056: Exercise and inflammation on the risk of cancer Cancer Research. 79: 5056-5056. DOI: 10.1158/1538-7445.Am2019-5056 |
0.453 |
|
| 2019 |
Schaeffer ML, May BJ, Hogan BC, Orellana MM, Petry D, Fiallos K, McCullough MS, Armstrong DK, Myers K, Visvanathan K. Abstract 2423: Longitudinal examination of breast cancer screening adherence among women in a prospective familial cohort Cancer Research. 79: 2423-2423. DOI: 10.1158/1538-7445.Am2019-2423 |
0.551 |
|
| 2018 |
Fortner RT, Poole EM, Wentzensen NA, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, et al. Ovarian cancer risk factors by tumor aggressiveness: an analysis from the Ovarian Cancer Cohort Consortium. International Journal of Cancer. PMID 30561796 DOI: 10.1002/Ijc.32075 |
0.49 |
|
| 2018 |
Button B, Croessmann S, Chu D, Rosen DM, Zabransky DJ, Dalton WB, Cravero K, Kyker-Snowman K, Waters I, Karthikeyan S, Christenson ES, Donaldson J, Hunter T, Dennison L, Ramin C, ... ... Visvanathan K, et al. The estrogen receptor-alpha S118P variant does not affect breast cancer incidence or response to endocrine therapies. Breast Cancer Research and Treatment. PMID 30560461 DOI: 10.1007/S10549-018-05087-7 |
0.472 |
|
| 2018 |
Nichols HB, Schoemaker MJ, Cai J, Xu J, Wright LB, Brook MN, Jones ME, Adami HO, Baglietto L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Dorronsoro M, Dossus L, Eliassen AH, ... ... Visvanathan K, et al. Breast Cancer Risk After Recent Childbirth: A Pooled Analysis of 15 Prospective Studies. Annals of Internal Medicine. PMID 30534999 DOI: 10.7326/M18-1323 |
0.732 |
|
| 2018 |
Huyghe JR, Bien SA, Harrison TA, Kang HM, Chen S, Schmit SL, Conti DV, Qu C, Jeon J, Edlund CK, Greenside P, Wainberg M, Schumacher FR, Smith JD, Levine DM, ... ... Visvanathan K, et al. Discovery of common and rare genetic risk variants for colorectal cancer. Nature Genetics. PMID 30510241 DOI: 10.1038/S41588-018-0286-6 |
0.339 |
|
| 2018 |
Fanidi A, Carreras-Torres R, Larose TL, Yuan JM, Stevens VL, Weinstein SJ, Albanes D, Prentice R, Pettinger M, Cai Q, Blot WJ, Arslan AA, Zeleniuch-Jacquotte A, McCullough ML, Le Marchand L, ... ... Visvanathan K, et al. Is high vitamin B12 status a cause of lung cancer? International Journal of Cancer. PMID 30499135 DOI: 10.1002/Ijc.32033 |
0.377 |
|
| 2018 |
Travis RC, Perez-Cornago A, Appleby PN, Albanes D, Joshu CE, Lutsey PL, Mondul AM, Platz EA, Weinstein SJ, Layne TM, Helzlsouer KJ, Visvanathan K, Palli D, Peeters PH, Bueno-de-Mesquita B, et al. A collaborative analysis of individual participant data from 19 prospective studies assesses circulating vitamin D and prostate cancer risk. Cancer Research. PMID 30425058 DOI: 10.1158/0008-5472.Can-18-2318 |
0.384 |
|
| 2018 |
Ramin C, May BJ, Roden RBS, Orellana MM, Hogan BC, McCullough MS, Petry D, Armstrong DK, Visvanathan K. Evaluation of osteopenia and osteoporosis in younger breast cancer survivors compared with cancer-free women: a prospective cohort study. Breast Cancer Research : Bcr. 20: 134. PMID 30424783 DOI: 10.1186/S13058-018-1061-4 |
0.562 |
|
| 2018 |
Butt J, Varga MG, Blot WJ, Teras L, Visvanathan K, Le Marchand L, Haiman C, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GYF, Tinker LE, Peek RM, Potter JD, et al. Serological response to Helicobacter pylori proteins associate with risk of colorectal cancer among diverse populations in the United States. Gastroenterology. PMID 30296434 DOI: 10.1053/J.Gastro.2018.09.054 |
0.4 |
|
| 2018 |
Visvanathan K, Shaw P, May BJ, Bahadirli-Talbot A, Kaushiva A, Risch H, Narod S, Wang TL, Parkash V, Vang R, Levine DA, Soslow R, Kurman R, Shih IM. Fallopian tube lesions in women at high risk for ovarian cancer: A multicenter study. Cancer Prevention Research (Philadelphia, Pa.). PMID 30232083 DOI: 10.1158/1940-6207.Capr-18-0009 |
0.447 |
|
| 2018 |
Dean LT, Moss SL, Ransome Y, Frasso-Jaramillo L, Zhang Y, Visvanathan K, Nicholas LH, Schmitz KH. "It still affects our economic situation": long-term economic burden of breast cancer and lymphedema. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer. PMID 30121786 DOI: 10.1007/S00520-018-4418-4 |
0.529 |
|
| 2018 |
Gross AL, Blot WJ, Visvanathan K. BRCA1 and BRCA2 Testing in Medically Underserved Medicare Beneficiaries With Breast or Ovarian Cancer. Jama. 320: 597-598. PMID 30120466 DOI: 10.1001/Jama.2018.8258 |
0.502 |
|
| 2018 |
Butt J, Blot WJ, Teras LR, Visvanathan K, Le Marchand L, Haiman CA, Chen Y, Bao Y, Sesso HD, Wassertheil-Smoller S, Ho GY, Tinker LF, Peek RM, Potter JD, Cover TL, et al. Antibody responses to Streptococcus gallolyticus subspecies gallolyticus proteins in a large prospective colorectal cancer cohort consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30038049 DOI: 10.1158/1055-9965.Epi-18-0249 |
0.343 |
|
| 2018 |
Schoemaker MJ, Nichols HB, Wright LB, Brook MN, Jones ME, O'Brien KM, Adami HO, Baglietto L, Bernstein L, Bertrand KA, Boutron-Ruault MC, Braaten T, Chen Y, Connor AE, ... ... Visvanathan K, et al. Association of Body Mass Index and Age With Subsequent Breast Cancer Risk in Premenopausal Women. Jama Oncology. e181771. PMID 29931120 DOI: 10.1001/Jamaoncol.2018.1771 |
0.736 |
|
| 2018 |
Larose TL, Guida F, Fanidi A, Langhammer A, Kveem K, Stevens VL, Jacobs EJ, Smith-Warner SA, Giovannucci E, Albanes D, Weinstein SJ, Freedman ND, Prentice R, Pettinger M, Thomson CA, ... ... Visvanathan K, et al. Circulating cotinine concentrations and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). International Journal of Epidemiology. PMID 29901778 DOI: 10.1093/Ije/Dyy100 |
0.408 |
|
| 2018 |
Trabert B, Poole EM, White E, Visvanathan K, Adami HO, Anderson GL, Brasky TM, Brinton LA, Fortner RT, Gaudet M, Hartge P, Hoffman-Bolton J, Jones M, Lacey JV, Larsson SC, et al. Analgesic Use and Ovarian Cancer Risk: An Analysis in the Ovarian Cancer Cohort Consortium. Journal of the National Cancer Institute. PMID 29860330 DOI: 10.1097/Ogx.0000000000000601 |
0.517 |
|
| 2018 |
Dean LT, Gehlert S, Neuhouser ML, Oh A, Zanetti K, Goodman M, Thompson B, Visvanathan K, Schmitz KH. Social factors matter in cancer risk and survivorship. Cancer Causes & Control : Ccc. PMID 29846844 DOI: 10.1007/S10552-018-1043-Y |
0.495 |
|
| 2018 |
Huang BZ, Tsilidis KK, Smith MW, Hoffman-Bolton J, Visvanathan K, Platz EA, Joshu CE. Polymorphisms in genes related to inflammation and obesity and colorectal adenoma risk. Molecular Carcinogenesis. PMID 29802748 DOI: 10.1002/Mc.22842 |
0.313 |
|
| 2018 |
Igusa T, Hummers LK, Visvanathan K, Richardson C, Wigley FM, Casciola-Rosen L, Rosen A, Shah AA. Autoantibodies and scleroderma phenotype define subgroups at high-risk and low-risk for cancer. Annals of the Rheumatic Diseases. PMID 29678941 DOI: 10.1136/Annrheumdis-2018-212999 |
0.512 |
|
| 2018 |
Umstead KL, Kalia SS, Madeo AC, Erby LH, Blank TO, Visvanathan K, Roter DL. Social comparisons and quality of life following a prostate cancer diagnosis. Journal of Psychosocial Oncology. 1-14. PMID 29424665 DOI: 10.1080/07347332.2017.1417950 |
0.312 |
|
| 2018 |
Klein AP, Wolpin BM, Risch HA, Stolzenberg-Solomon RZ, Mocci E, Zhang M, Canzian F, Childs EJ, Hoskins JW, Jermusyk A, Zhong J, Chen F, Albanes D, Andreotti G, Arslan AA, ... ... Visvanathan K, et al. Genome-wide meta-analysis identifies five new susceptibility loci for pancreatic cancer. Nature Communications. 9: 556. PMID 29422604 DOI: 10.1038/S41467-018-02942-5 |
0.385 |
|
| 2018 |
Dean LT, Schmitz KH, Frick KD, Nicholas LH, Zhang Y, Subramanian SV, Visvanathan K. Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA. Journal of Cancer Survivorship : Research and Practice. PMID 29372485 DOI: 10.1007/S11764-017-0669-1 |
0.481 |
|
| 2018 |
Murto MO, Artama M, Pukkala E, Visvanathan K, Murtola TJ. Breast cancer extent and survival among diabetic women in a Finnish nationwide cohort study. International Journal of Cancer. PMID 29318620 DOI: 10.1002/Ijc.31250 |
0.454 |
|
| 2018 |
Ge W, Clendenen TV, Afanasyeva Y, Koenig KL, Agnoli C, Brinton LA, Dorgan JF, Eliassen AH, Falk RT, Hallmans G, Hankinson SE, Hoffman-Bolton J, Key TJ, Krogh V, Nichols HB, ... ... Visvanathan K, et al. Circulating Anti-Müllerian Hormone and Breast Cancer Risk: A Study in Ten Prospective Cohorts. International Journal of Cancer. PMID 29315564 DOI: 10.1002/Ijc.31249 |
0.732 |
|
| 2018 |
Pollack CE, Radhakrishnan A, Parker AM, Chen X, Visvanathan K, Nowak SA. Association Between Physicians' Experiences With Members of Their Social Network and Efforts to Reduce Breast Cancer Screening. Jama Internal Medicine. 178: 148-151. PMID 29204657 DOI: 10.1001/Jamainternmed.2017.6871 |
0.441 |
|
| 2018 |
Fanidi A, Muller DC, Yuan JM, Stevens VL, Weinstein SJ, Albanes D, Prentice R, Thomsen CA, Pettinger M, Cai Q, Blot WJ, Wu J, Arslan AA, Zeleniuch-Jacquotte A, McCullough ML, ... ... Visvanathan K, et al. Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3). Journal of the National Cancer Institute. 110. PMID 28922778 DOI: 10.1093/Jnci/Djx119 |
0.435 |
|
| 2018 |
Chen WY, Winer EP, Ballman KV, Partridge AH, Carey LA, Carvan M, Matyka C, Openshaw TH, Visvanathan K, Symington B, Holmes MD. ABC trial (A011502): A randomized phase III double-blinded placebo controlled trial of aspirin as adjuvant therapy breast cancer. Journal of Clinical Oncology. 36. DOI: 10.1200/Jco.2020.38.15_Suppl.Tps600 |
0.464 |
|
| 2018 |
Handy C, Al-Mallah MH, Dardari Z, Brawner CA, Lamerato LE, Keteyian S, Ehrman JK, Visvanathan K, Blaha MJ. Cardiorespiratory fitness and incident lung and colon cancer: FIT-Cancer Cohort. Journal of Clinical Oncology. 36: 1502-1502. DOI: 10.1200/Jco.2018.36.15_Suppl.1502 |
0.485 |
|
| 2018 |
Connor A, Visvanathan K, Boone S, Baumgartner K, Baumgartner R. Abstract P6-10-03: The association between type-2 diabetes and risk of mortality after invasive breast cancer among Hispanic and non-Hispanic white women from New Mexico Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P6-10-03 |
0.518 |
|
| 2018 |
Ramin C, May B, Roden R, McCullough M, Armstrong D, Visvanathan K. Abstract P6-08-12: Understanding the etiology of osteopenia and osteoporosis in young breast cancer survivors compared to cancer-free women Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P6-08-12 |
0.577 |
|
| 2018 |
Fackler M, Downs B, Mercado-Rodriguez C, Cimino-Mathews A, Chen C, Yuan J, Cope L, Kohlway A, Kocmond K, Lai E, Weidler J, Visvanathan K, Umbricht C, Harvey S, Wolff A, et al. Abstract P6-03-07: An automated DNA methylation assay (QM-MSP) for rapid breast cancer diagnosis in underdeveloped countries Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P6-03-07 |
0.484 |
|
| 2018 |
Smith K, Yeruva S, Blackford A, Huang C, Westbrook K, Harding B, Smith A, Fetting J, Wolff A, Jelovac D, Miller R, Connolly R, Armstrong D, Nunes R, Visvanathan K, et al. Abstract P3-12-02: Predictors of adherence to adjuvant endocrine therapy (ET) for early breast cancer (BC) in a prospective clinic-based cohort Cancer Research. 78. DOI: 10.1158/1538-7445.Sabcs17-P3-12-02 |
0.424 |
|
| 2018 |
Purdue MP, Lan Q, Hoffman-Bolton J, Hildesheim A, Strickland P, Visvanathan K, Rothman N. Abstract 3232: Circulating sCD27 and sCD30 in samples collected fifteen years apart and non-Hodgkin lymphoma risk: Findings from the CLUE-I and CLUE-II cohorts Cancer Research. 78: 3232-3232. DOI: 10.1158/1538-7445.Am2018-3232 |
0.365 |
|
| 2018 |
Trabert B, Poole EM, White E, Visvanathan K, Adami H, Anderson GL, Brasky TM, Brinton LA, Fortner RT, Gaudet M, Hartge P, Hoffman-Bolton J, Jones M, Lacey JV, Larsson SC, et al. Analgesic Use and Ovarian Cancer Risk Obstetrical & Gynecological Survey. 73: 576-578. DOI: 10.1097/OGX.0000000000000601 |
0.387 |
|
| 2017 |
Nichols HB, Stürmer T, Lee VS, Anderson C, Lee JS, Roh JM, Visvanathan K, Muss H, Kushi LH. Breast Cancer Chemoprevention in an Integrated Health Care Setting. Jco Clinical Cancer Informatics. 1: 1-12. PMID 30657366 DOI: 10.1200/CCI.16.00059 |
0.67 |
|
| 2017 |
Visvanathan K, Wang TL, Shih IM. Precancerous Lesions of Ovarian Cancer-A US Perspective. Journal of the National Cancer Institute. PMID 29281080 DOI: 10.1093/Jnci/Djx269 |
0.392 |
|
| 2017 |
Joshu CE, Barber JR, Coresh J, Couper DJ, Mosley TH, Vitolins MZ, Butler KR, Nelson HH, Prizment AE, Selvin E, Tooze JA, Visvanathan K, Folsom AR, Platz EA. Enhancing the Infrastructure of the Atherosclerosis Risk in Communities (ARIC) Study for Cancer Epidemiology Research: ARIC Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29263187 DOI: 10.1158/1055-9965.Epi-17-0696 |
0.456 |
|
| 2017 |
Theofylaktopoulou D, Midttun Ø, Ueland PM, Meyer K, Fanidi A, Zheng W, Shu XO, Xiang YB, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, Blot WJ, ... ... Visvanathan K, et al. Impaired functional vitamin B6 status is associated with increased risk of lung cancer. International Journal of Cancer. PMID 29238985 DOI: 10.1002/Ijc.31215 |
0.426 |
|
| 2017 |
Radhakrishnan A, Nowak SA, Parker AM, Visvanathan K, Pollack CE. Linking physician attitudes to their breast cancer screening practices: A survey of US primary care providers and gynecologists. Preventive Medicine. PMID 29155227 DOI: 10.1016/J.Ypmed.2017.11.010 |
0.396 |
|
| 2017 |
Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, ... ... Visvanathan K, et al. Anti-Müllerian Hormone and risk of ovarian cancer in nine cohorts. International Journal of Cancer. PMID 28921520 DOI: 10.1002/Ijc.31058 |
0.512 |
|
| 2017 |
Murphy L, Brown C, Smith A, Cranfield F, Sharp L, Visvanathan K, Bennett K, Barron TI. End-of-life prescribing of aspirin in patients with breast or colorectal cancer. Bmj Supportive & Palliative Care. PMID 28838931 DOI: 10.1136/Bmjspcare-2017-001370 |
0.456 |
|
| 2017 |
Shah AA, Rosen A, Hummers LK, May BJ, Kaushiva A, Roden RBS, Armstrong DK, Wigley FM, Casciola-Rosen L, Visvanathan K. Evaluation of cancer-associated myositis and scleroderma autoantibodies in breast cancer patients without rheumatic disease. Clinical and Experimental Rheumatology. PMID 28628466 |
0.42 |
|
| 2017 |
Nichols HB, Schoemaker MJ, Wright LB, McGowan C, Brook MN, McClain KM, Jones ME, Adami HO, Agnoli C, Baglietto L, Bernstein L, Bertrand KA, Blot WJ, Boutron-Ruault MC, Butler L, ... ... Visvanathan K, et al. The Premenopausal Breast Cancer Collaboration: A pooling project of studies participating in the National Cancer Institute Cohort Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28600297 DOI: 10.1158/1055-9965.Epi-17-0246 |
0.745 |
|
| 2017 |
Radhakrishnan A, Nowak SA, Parker AM, Visvanathan K, Pollack CE. Physician Breast Cancer Screening Recommendations Following Guideline Changes: Results of a National Survey. Jama Internal Medicine. PMID 28395005 DOI: 10.1001/Jamainternmed.2017.0453 |
0.467 |
|
| 2017 |
Ose J, Poole EM, Schock H, Lehtinen M, Arslan AA, Zeleniuch-Jacquotte A, Visvanathan K, Helzlsouer KJ, Buring JE, Lee IM, Tjønneland A, Dossus L, Trichopoulou A, Masala G, Onland-Moret NC, et al. Androgens are differentially associated with ovarian cancer subtypes in the Ovarian Cancer Cohort Consortium. Cancer Research. PMID 28381542 DOI: 10.1158/0008-5472.Can-16-3322 |
0.468 |
|
| 2017 |
Jung S, Allen N, Arslan AA, Baglietto L, Brinton LA, Egleston BL, Falk R, Fortner RT, Helzlsouer KJ, Idahl A, Kaaks R, Lundin E, Merritt M, Onland-Moret C, Rinaldi S, ... ... Visvanathan K, et al. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women. Fertility and Sterility. 107: 1012-1022.e2. PMID 28366409 DOI: 10.1016/J.Fertnstert.2017.02.105 |
0.321 |
|
| 2017 |
Barton V, Armeson K, Hampras S, Ferris LK, Visvanathan K, Rollison D, Alberg AJ. Nonmelanoma skin cancer and risk of all-cause and cancer-related mortality: a systematic review. Archives of Dermatological Research. PMID 28285366 DOI: 10.1007/S00403-017-1724-5 |
0.451 |
|
| 2017 |
Ose J, Schock H, Poole EM, Lehtinen M, Visvanathan K, Helzlsouer K, Buring JE, Lee IM, Tjønneland A, Boutron-Ruault MC, Trichopoulou A, Mattiello A, Onland-Moret NC, Weiderpass E, Sánchez MJ, et al. Pre-diagnosis insulin-like growth factor-I and risk of epithelial invasive ovarian cancer by histological subtypes: A collaborative re-analysis from the Ovarian Cancer Cohort Consortium. Cancer Causes & Control : Ccc. PMID 28205047 DOI: 10.1007/S10552-017-0852-8 |
0.416 |
|
| 2017 |
Chen WY, Winer EP, Barry WT, Hudis CA, Openshaw TH, Visvanathan K, Symington B, Matyka C, Holmes MD. ABC trial (A011502): A randomized phase III double blinded placebo controlled trial of aspirin as adjuvant therapy for node positive breast cancer. Journal of Clinical Oncology. 35: TPS586-TPS586. DOI: 10.1200/Jco.2017.35.15_Suppl.Tps586 |
0.473 |
|
| 2017 |
Pollack CE, Radhakrishnan A, Parker AM, Visvanathan K, Nowak SA. Are physicians social networks linked to breast cancer screening recommendations for older adults? Journal of Clinical Oncology. 35: 6550-6550. DOI: 10.1200/Jco.2017.35.15_Suppl.6550 |
0.472 |
|
| 2017 |
Teras LR, Patel AV, Wang M, Caan BJ, Chen Y, Connor AE, Eliassen AH, Gapstur SM, Gaudet MM, Genkinger JM, Giles GG, Lee I, Milne R, Sawada N, Sesso HD, ... ... Visvanathan K, et al. Abstract 5311: Weight loss over 10 years of adulthood and subsequent risk of breast cancer: a pooled analysis of 11 cohort studies Cancer Research. 77: 5311-5311. DOI: 10.1158/1538-7445.Am2017-5311 |
0.538 |
|
| 2017 |
Connor AE, Visvanathan K, Boone SD, Baumgartner RN, Baumgartner KB. Abstract 5274: Risk of comorbidities among Hispanic and non-Hispanic white breast cancer survivors compared to breast cancer free women Epidemiology. 77: 5274-5274. DOI: 10.1158/1538-7445.Am2017-5274 |
0.595 |
|
| 2017 |
Dean LT, Schmitz KH, Frick K, Nicholas L, Zhang Y, Subramanian S, Visvanathan K. Abstract 4217: Consumer credit, cancer treatment, and health among women with a history of breast cancer Cancer Research. 77: 4217-4217. DOI: 10.1158/1538-7445.Am2017-4217 |
0.559 |
|
| 2017 |
Murto M, Artama M, Visvanathan K, Murtola T. Abstract 3294: Breast cancer extent and survival in diabetic women in a Finnish population based cohort Epidemiology. 77: 3294-3294. DOI: 10.1158/1538-7445.Am2017-3294 |
0.489 |
|
| 2017 |
Ramin CA, May BJ, Roden RB, Petry D, Armstrong DK, Visvanathan K. Abstract 3271: Evaluation of bone health in breast cancer survivors compared to cancer-free women: A prospective study within a young familial risk cohort Epidemiology. 77: 3271-3271. DOI: 10.1158/1538-7445.Am2017-3271 |
0.556 |
|
| 2016 |
Kim HS, Umbricht CB, Illei PB, Cimino-Mathews A, Cho S, Chowdhury N, Figueroa-Magalhaes MC, Pesce C, Jeter SC, Mylander C, Rosman M, Tafra L, Turner BM, Hicks DG, Jensen TA, ... ... Visvanathan K, et al. Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 4390-4397. PMID 27998227 DOI: 10.1200/Jco.2016.67.7195 |
0.387 |
|
| 2016 |
Cardwell CR, Pottegård A, Vaes E, Garmo H, Murray LJ, Brown C, Vissers PA, O'Rorke M, Visvanathan K, Cronin-Fenton D, De Schutter H, Lambe M, Powe DG, van Herk-Sukel MP, Gavin A, et al. Propranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts. Breast Cancer Research : Bcr. 18: 119. PMID 27906047 DOI: 10.1186/S13058-016-0782-5 |
0.561 |
|
| 2016 |
Visvanathan K, Fackler MS, Zhang Z, Lopez-Bujanda ZA, Jeter SC, Sokoll LJ, Garrett-Mayer E, Cope LM, Umbricht CB, Euhus DM, Forero A, Storniolo AM, Nanda R, Lin NU, Carey LA, et al. Monitoring of Serum DNA Methylation as an Early Independent Marker of Response and Survival in Metastatic Breast Cancer: TBCRC 005 Prospective Biomarker Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2015662080. PMID 27870562 DOI: 10.1200/Jco.2015.66.2080 |
0.436 |
|
| 2016 |
Connor AE, Visvanathan K, Baumgartner KB, Baumgartner RN, Boone SD, Hines LM, Wolff RK, John EM, Slattery ML. Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study. Breast Cancer Research and Treatment. PMID 27837379 DOI: 10.1007/S10549-016-4048-9 |
0.538 |
|
| 2016 |
Horick NK, Manful A, Lowery J, Domchek S, Moorman P, Griffin C, Visvanathan K, Isaacs C, Kinney AY, Finkelstein DM. Physical and psychological health in rare cancer survivors. Journal of Cancer Survivorship : Research and Practice. PMID 27761785 DOI: 10.1007/S11764-016-0573-0 |
0.458 |
|
| 2016 |
Visvanathan K, Yager JD. Ethnic Variations in Estrogen and Its Metabolites: Sufficient to Explain Differences in Breast Cancer Incidence Rates? Journal of the National Cancer Institute. 108. PMID 27737914 DOI: 10.1093/jnci/djw223 |
0.427 |
|
| 2016 |
Narayan AK, Visvanathan K, Harvey SC. Comparative effectiveness of breast MRI and mammography in screening young women with elevated risk of developing breast cancer: a retrospective cohort study. Breast Cancer Research and Treatment. PMID 27444927 DOI: 10.1007/S10549-016-3912-Y |
0.561 |
|
| 2016 |
Visvanathan K, Yager JD. Ethnic Variations in Estrogen and Its Metabolites: Sufficient to Explain Differences in Breast Cancer Incidence Rates? Journal of the National Cancer Institute. 108. PMID 27381625 DOI: 10.1093/Jnci/Djw147 |
0.52 |
|
| 2016 |
Wentzensen N, Poole EM, Trabert B, White E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, Adami HO, Black A, Bernstein L, Brinton LA, Buring J, Butler LM, et al. Ovarian Cancer Risk Factors by Histologic Subtype: An Analysis From the Ovarian Cancer Cohort Consortium. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27325851 DOI: 10.1200/Jco.2016.66.8178 |
0.502 |
|
| 2016 |
Connor AE, Visvanathan K, Baumgartner KB, Baumgartner RN, Boone SD, Hines LM, Wolff RK, John EM, Slattery ML. Ethnic differences in the relationships between diabetes, early age adiposity and mortality among breast cancer survivors: the Breast Cancer Health Disparities Study. Breast Cancer Research and Treatment. PMID 27116186 DOI: 10.1007/S10549-016-3810-3 |
0.458 |
|
| 2016 |
Connor AE, Visvanathan K, Baumgartner KB, Baumgartner RN, Boone SD, Hines LM, Giuliano AR, Wolff RK, John EM, Slattery ML. Abstract C51: Ethnic differences in the relationship between diabetes, early age adiposity, and mortality among breast cancer survivors: The Breast Cancer Health Disparities Study Cancer Epidemiology, Biomarkers & Prevention. 25. DOI: 10.1158/1538-7755.Disp15-C51 |
0.487 |
|
| 2016 |
Connor AE, Visvanathan K, Baumgartner KB, Baumgartner RN, Boone SD, Hines LM, Giuliano AR, John EM, Wolff RK, Slattery ML. Abstract LB-363: Breastfeeding, parity and risk of mortality among Hispanic and non-Hispanic white women diagnosed with breast cancer: the Breast Cancer Health Disparities Study Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-363 |
0.551 |
|
| 2016 |
Kaushiva A, May B, Armstrong D, Axilbund J, Visvanathan K. Abstract 2544: Association between flame-broiled fish consumption and breast cancer: A case-control study in women with high familial risk Cancer Research. 76: 2544-2544. DOI: 10.1158/1538-7445.Am2016-2544 |
0.532 |
|
| 2015 |
Wu K, Spiegelman D, Hou T, Albanes D, Allen NE, Berndt SI, van den Brandt PA, Giles GG, Giovannucci E, Goldbohm RA, Goodman GG, Goodman PJ, Håkansson N, Inoue M, Key TJ, ... ... Visvanathan K, et al. Associations between unprocessed red and processed meat, poultry, seafood and egg intake and the risk of prostate cancer: A pooled analysis of 15 prospective cohort studies. International Journal of Cancer. Journal International Du Cancer. PMID 26685908 DOI: 10.1002/Ijc.29973 |
0.343 |
|
| 2015 |
Sampson JN, Wheeler WA, Yeager M, Panagiotou O, Wang Z, Berndt SI, Lan Q, Abnet CC, Amundadottir LT, Figueroa JD, Landi MT, Mirabello L, Savage SA, Taylor PR, Vivo ID, ... ... Visvanathan K, et al. Analysis of Heritability and Shared Heritability Based on Genome-Wide Association Studies for Thirteen Cancer Types. Journal of the National Cancer Institute. 107. PMID 26464424 DOI: 10.1093/Jnci/Djv279 |
0.416 |
|
| 2015 |
Genkinger JM, Kitahara CM, Bernstein L, Berrington de Gonzalez A, Brotzman M, Elena JW, Giles GG, Hartge P, Singh PN, Stolzenberg-Solomon RZ, Weiderpass E, Adami HO, Anderson KE, Beane-Freeman LE, Buring JE, ... ... Visvanathan K, et al. Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26347100 DOI: 10.1093/Annonc/Mdv355 |
0.409 |
|
| 2015 |
Jung S, Wang M, Anderson K, Baglietto L, Bergkvist L, Bernstein L, van den Brandt PA, Brinton L, Buring JE, Heather Eliassen A, Falk R, Gapstur SM, Giles GG, Goodman G, Hoffman-Bolton J, ... ... Visvanathan K, et al. Alcohol consumption and breast cancer risk by estrogen receptor status: in a pooled analysis of 20 studies. International Journal of Epidemiology. PMID 26320033 DOI: 10.1093/Ije/Dyv156 |
0.529 |
|
| 2015 |
Tao JJ, Visvanathan K, Wolff AC. Long term side effects of adjuvant chemotherapy in patients with early breast cancer. Breast (Edinburgh, Scotland). PMID 26299406 DOI: 10.1016/j.breast.2015.07.035 |
0.357 |
|
| 2015 |
Gross AL, May BJ, Axilbund JE, Armstrong DK, Roden RB, Visvanathan K. Weight change in breast cancer survivors compared to cancer-free women: a prospective study in women at familial risk of breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1262-9. PMID 26178712 DOI: 10.1158/1055-9965.Epi-15-0212 |
0.595 |
|
| 2015 |
Bevers TB, Ward JH, Arun BK, Colditz GA, Cowan KH, Daly MB, Garber JE, Gemignani ML, Gradishar WJ, Jordan JA, Korde LA, Kounalakis N, Krontiras H, Kumar S, Kurian A, ... ... Visvanathan K, et al. Breast Cancer Risk Reduction, Version 2.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 880-915. PMID 26150582 DOI: 10.6004/Jnccn.2015.0105 |
0.609 |
|
| 2015 |
Kobayashi Y, Kashima H, Wu RC, Jung JG, Kuan JC, Gu J, Xuan J, Sokoll L, Visvanathan K, Shih IM, Wang TL. Mevalonate Pathway Antagonist Inhibits Proliferation of Serous Tubal Intraepithelial Carcinoma and Ovarian Carcinoma in Mouse Models. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26109099 DOI: 10.1158/1078-0432.Ccr-14-3368 |
0.345 |
|
| 2015 |
Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Amundadottir LT, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Chanock SJ, ... ... Visvanathan K, et al. Correction: Vitamin D Metabolic Pathway Genes and Pancreatic Cancer Risk. Plos One. 10: e0129983. PMID 26039095 DOI: 10.1371/Journal.Pone.0129983 |
0.405 |
|
| 2015 |
Campa D, Rizzato C, Stolzenberg-Solomon R, Pacetti P, Vodicka P, Cleary SP, Capurso G, Bueno-de-Mesquita HB, Werner J, Gazouli M, Butterbach K, Ivanauskas A, Giese N, Petersen GM, Fogar P, ... ... Visvanathan K, et al. TERT gene harbors multiple variants associated with pancreatic cancer susceptibility. International Journal of Cancer. Journal International Du Cancer. PMID 25940397 DOI: 10.1002/Ijc.29590 |
0.392 |
|
| 2015 |
Arem H, Yu K, Xiong X, Moy K, Freedman ND, Mayne ST, Albanes D, Arslan AA, Austin M, Bamlet WR, Beane-Freeman L, Bracci P, Canzian F, Cotterchio M, Duell EJ, ... ... Visvanathan K, et al. Vitamin D metabolic pathway genes and pancreatic cancer risk. Plos One. 10: e0117574. PMID 25799011 DOI: 10.1371/Journal.Pone.0117574 |
0.394 |
|
| 2015 |
Barron TI, Murphy LM, Brown C, Bennett K, Visvanathan K, Sharp L. De Novo Post-Diagnosis Aspirin Use and Mortality in Women with Stage I-III Breast Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 898-904. PMID 25791705 DOI: 10.1158/1055-9965.Epi-14-1415 |
0.554 |
|
| 2015 |
Shah AA, Hummers LK, Casciola-Rosen L, Visvanathan K, Rosen A, Wigley FM. Examination of autoantibody status and clinical features associated with cancer risk and cancer-associated scleroderma. Arthritis & Rheumatology (Hoboken, N.J.). 67: 1053-61. PMID 25605296 DOI: 10.1002/Art.39022 |
0.502 |
|
| 2015 |
Wolff AC, Blackford AL, Visvanathan K, Rugo HS, Moy B, Goldstein LJ, Stockerl-Goldstein K, Neumayer L, Langbaum TS, Theriault RL, Hughes ME, Weeks JC, Karp JE. Risk of marrow neoplasms after adjuvant breast cancer therapy: the national comprehensive cancer network experience. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 340-8. PMID 25534386 DOI: 10.1200/Jco.2013.54.6119 |
0.546 |
|
| 2015 |
Visvanathan K, Fackler MJ, Zhang Z, Lopez-Bujanda Z, Jeter S, Sokoll LJ, Cope L, Umbricht C, Euhus D, Carpenter JT, Storniolo AM, Nanda R, Lin NU, Carey LA, Ingle JN, et al. DNA methylation in serum as an independent marker of outcome and treatment response in TBCRC 005: A prospective study in metastatic breast cancer (MBC) patients. Journal of Clinical Oncology. 33: 518-518. DOI: 10.1200/Jco.2015.33.15_Suppl.518 |
0.343 |
|
| 2015 |
Tworoger SS, Poole EM, Arslan AA, Butler LM, Kirsh V, Lacey JV, Lee I, Patel AV, Robien K, Rohan T, Sandler DP, Schouten LJ, Setiawan VW, Visvanathan K, Weiderpass E, et al. Abstract AS10: Ovarian cancer risk factor associations by tumor aggressiveness in the ovarian cancer cohort consortium (OC3) Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Ovcasymp14-As10 |
0.542 |
|
| 2015 |
Gross AL, Davidovics SA, Armstrong DK, Axilbund JE, May BJ, Visvanathan K. Abstract P6-10-11: Longitudinal comparison of weight change in breast cancer survivors to cancer-free women: a prospective study in women with a familial risk of breast cancer Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P6-10-11 |
0.569 |
|
| 2015 |
Visvanathan K, Mondul A, Zeleniuch-Jacquotte A, Mukhtar TK, Smith-Warner SA, Ziegler RG. Abstract P3-07-01: Circulating vitamin D concentrations and breast cancer risk: A pooled analysis of 17 cohorts Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P3-07-01 |
0.501 |
|
| 2015 |
Connor AE, Visvanathan K, Baumgartner K, Baumgartner RN, Boone S, Hines LM, Giuliano AR, John EM, Wolff RK, Slattery ML. Abstract LB-190: Ethnic differences in the relationship between diabetes, adiposity measures and breast cancer-specific mortality Epidemiology. 75. DOI: 10.1158/1538-7445.Am2015-Lb-190 |
0.466 |
|
| 2015 |
Wentzensen NA, Poole E, Arslan AA, Patel AV, Setiawan VW, Visvanathan K, Weiderpass E, White E, Adami H, Brinton LA, Bernstein L, Buring J, Butler LM, Chamosa S, Clendenen TV, et al. Abstract 854: Ovarian cancer risk factors by histologic subtypes: evidence for etiologic heterogeneity Cancer Research. 75: 854-854. DOI: 10.1158/1538-7445.Am2015-854 |
0.506 |
|
| 2014 |
Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E. Statin use and breast cancer survival: a nationwide cohort study from Finland. Plos One. 9: e110231. PMID 25329299 DOI: 10.1371/Journal.Pone.0110231 |
0.578 |
|
| 2014 |
Wolpin BM, Rizzato C, Kraft P, Kooperberg C, Petersen GM, Wang Z, Arslan AA, Beane-Freeman L, Bracci PM, Buring J, Canzian F, Duell EJ, Gallinger S, Giles GG, Goodman GE, ... ... Visvanathan K, et al. Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer. Nature Genetics. 46: 994-1000. PMID 25086665 DOI: 10.1038/Ng.3052 |
0.318 |
|
| 2014 |
Barron TI, Flahavan EM, Sharp L, Bennett K, Visvanathan K. Recent prediagnostic aspirin use, lymph node involvement, and 5-year mortality in women with stage I-III breast cancer: a nationwide population-based cohort study. Cancer Research. 74: 4065-77. PMID 25085874 DOI: 10.1158/0008-5472.Can-13-2679 |
0.485 |
|
| 2014 |
Kitahara CM, Flint AJ, Berrington de Gonzalez A, Bernstein L, Brotzman M, MacInnis RJ, Moore SC, Robien K, Rosenberg PS, Singh PN, Weiderpass E, Adami HO, Anton-Culver H, Ballard-Barbash R, Buring JE, ... ... Visvanathan K, et al. Association between class III obesity (BMI of 40-59 kg/m2) and mortality: a pooled analysis of 20 prospective studies. Plos Medicine. 11: e1001673. PMID 25003901 DOI: 10.1371/Journal.Pmed.1001673 |
0.327 |
|
| 2014 |
Teras LR, Kitahara CM, Birmann BM, Hartge PA, Wang SS, Robien K, Patel AV, Adami HO, Weiderpass E, Giles GG, Singh PN, Alavanja M, Beane Freeman LE, Bernstein L, Buring JE, ... ... Visvanathan K, et al. Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies. British Journal of Haematology. 166: 667-76. PMID 24861847 DOI: 10.1111/Bjh.12935 |
0.381 |
|
| 2014 |
Fackler MJ, Lopez Bujanda Z, Umbricht C, Teo WW, Cho S, Zhang Z, Visvanathan K, Jeter S, Argani P, Wang C, Lyman JP, de Brot M, Ingle JN, Boughey J, McGuire K, et al. Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer. Cancer Research. 74: 2160-70. PMID 24737128 DOI: 10.1158/0008-5472.Can-13-3392 |
0.51 |
|
| 2014 |
Horick N, Manful A, Kinney A, Lowery J, Domchek SM, Isaacs C, Visvanathan K, Griffin CA, Moorman P, Finkelstein DM. Late effects in rare cancer registrants. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E20577 |
0.406 |
|
| 2013 |
Tanner EJ, Long KC, Visvanathan K, Fader AN. Prophylactic salpingectomy in premenopausal women at low risk for ovarian cancer: risk-reducing or risky? Fertility and Sterility. 100: 1530-1. PMID 24182408 DOI: 10.1016/J.Fertnstert.2013.09.039 |
0.49 |
|
| 2013 |
Nichols HB, Trentham-Dietz A, Newcomb PA, Egan KM, Titus LJ, Hampton JM, Visvanathan K. Pre-diagnosis oophorectomy, estrogen therapy and mortality in a cohort of women diagnosed with breast cancer. Breast Cancer Research : Bcr. 15: R99. PMID 24152546 DOI: 10.1186/Bcr3560 |
0.724 |
|
| 2013 |
Prizment AE, Folsom AR, Dreyfus J, Anderson KE, Visvanathan K, Joshu CE, Platz EA, Pankow JS. Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study. Cancer Causes & Control : Ccc. 24: 2077-87. PMID 24036889 DOI: 10.1007/S10552-013-0285-Y |
0.535 |
|
| 2013 |
Visvanathan K, Hurley P, Bantug E, Brown P, Col NF, Cuzick J, Davidson NE, Decensi A, Fabian C, Ford L, Garber J, Katapodi M, Kramer B, Morrow M, Parker B, et al. Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 2942-62. PMID 23835710 DOI: 10.1200/Jco.2013.49.3122 |
0.47 |
|
| 2013 |
Bodelon C, Wentzensen N, Schonfeld SJ, Visvanathan K, Hartge P, Park Y, Pfeiffer RM. Hormonal risk factors and invasive epithelial ovarian cancer risk by parity. British Journal of Cancer. 109: 769-76. PMID 23820255 DOI: 10.1038/Bjc.2013.344 |
0.72 |
|
| 2013 |
Khaliq W, Visvanathan K, Landis R, Wright SM. Breast cancer screening preferences among hospitalized women. Journal of Women's Health (2002). 22: 637-42. PMID 23768020 DOI: 10.1089/Jwh.2012.4083 |
0.523 |
|
| 2013 |
Alberg AJ, Armeson K, Pierce JS, Bielawski J, Bielawska A, Visvanathan K, Hill EG, Ogretmen B. Plasma sphingolipids and lung cancer: a population-based, nested case-control study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1374-82. PMID 23749868 DOI: 10.1158/1055-9965.Epi-12-1424 |
0.379 |
|
| 2013 |
Gross AL, Newschaffer CJ, Hoffman-Bolton J, Rifai N, Visvanathan K. Adipocytokines, inflammation, and breast cancer risk in postmenopausal women: a prospective study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1319-24. PMID 23651666 DOI: 10.1158/1055-9965.Epi-12-1444 |
0.566 |
|
| 2013 |
McCarthy AM, Menke A, Visvanathan K. Association of bilateral oophorectomy and body fatness in a representative sample of US women. Gynecologic Oncology. 129: 559-64. PMID 23428461 DOI: 10.1016/J.Ygyno.2013.02.016 |
0.591 |
|
| 2013 |
Matsuno RK, Sherman ME, Visvanathan K, Goodman MT, Hernandez BY, Lynch CF, Ioffe OB, Horio D, Platz C, Altekruse SF, Pfeiffer RM, Anderson WF. Agreement for tumor grade of ovarian carcinoma: analysis of archival tissues from the surveillance, epidemiology, and end results residual tissue repository. Cancer Causes & Control : Ccc. 24: 749-57. PMID 23378140 DOI: 10.1007/S10552-013-0157-5 |
0.355 |
|
| 2013 |
Jung S, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Cerhan JR, Gaudet MM, Giles GG, Goodman G, Hakansson N, Hankinson SE, Helzlsouer K, Horn-Ross PL, ... ... Visvanathan K, et al. Fruit and vegetable intake and risk of breast cancer by hormone receptor status. Journal of the National Cancer Institute. 105: 219-36. PMID 23349252 DOI: 10.1093/Jnci/Djs635 |
0.584 |
|
| 2013 |
Leenders M, Bhattacharjee S, Vineis P, Stevens V, Bueno-de-Mesquita HB, Shu XO, Amundadottir L, Gross M, Tobias GS, Wactawski-Wende J, Arslan AA, Duell EJ, Fuchs CS, Gallinger S, Hartge P, ... ... Visvanathan K, et al. Polymorphisms in genes related to one-carbon metabolism are not related to pancreatic cancer in PanScan and PanC4. Cancer Causes & Control : Ccc. 24: 595-602. PMID 23334854 DOI: 10.1007/S10552-012-0138-0 |
0.329 |
|
| 2013 |
Schonfeld SJ, Berrington de Gonzalez A, Visvanathan K, Pfeiffer RM, Anderson WF. Declining second primary ovarian cancer after first primary breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 738-43. PMID 23284037 DOI: 10.1200/Jco.2012.43.2757 |
0.754 |
|
| 2013 |
Schonfeld SJ, Hartge P, Pfeiffer RM, Freedman DM, Greenlee RT, Linet MS, Park Y, Schairer C, Visvanathan K, Lacey JV. An aggregated analysis of hormonal factors and endometrial cancer risk by parity. Cancer. 119: 1393-401. PMID 23280123 DOI: 10.1002/Cncr.27909 |
0.728 |
|
| 2013 |
Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, ... ... Visvanathan K, et al. Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes & Control : Ccc. 24: 13-25. PMID 23112111 DOI: 10.1007/S10552-012-0078-8 |
0.322 |
|
| 2013 |
Kensler TW, Egner PA, Agyeman AS, Visvanathan K, Groopman JD, Chen JG, Chen TY, Fahey JW, Talalay P. Keap1-nrf2 signaling: a target for cancer prevention by sulforaphane. Topics in Current Chemistry. 329: 163-77. PMID 22752583 DOI: 10.1007/128_2012_339 |
0.305 |
|
| 2013 |
Gross AL, Davidovics SA, Axilbund JE, Armstrong DK, May BJ, Visvanathan K. Longitudinal comparison of body mass index (BMI) in breast cancer survivors to cancer-free women: A prospective study in high-risk women. Journal of Clinical Oncology. 31: 1601-1601. DOI: 10.1200/Jco.2013.31.15_Suppl.1601 |
0.557 |
|
| 2013 |
Visvanathan K, Huynh M, Al-Lozi R, Oidtman J, May BJ, Ouyang P. Adiposity post prophylactic oophorectomy in young women at high risk for breast and ovarian cancer. Journal of Clinical Oncology. 31: 1572-1572. DOI: 10.1200/Jco.2013.31.15_Suppl.1572 |
0.455 |
|
| 2013 |
Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E. Breast cancer mortality among users of cholesterol-lowering drugs. Journal of Clinical Oncology. 31: 1514-1514. DOI: 10.1200/Jco.2013.31.15_Suppl.1514 |
0.548 |
|
| 2013 |
Yang L, Zahid M, Rogan EG, Cavalieri EL, Yager JD, Visvanathan K, Groopman J, Davidson NE, Kensler TW. Abstract 3679: Modulation of estrogen depurinating DNA adduct by sulforaphane or KEAP1 knockdown in human breast epithelial cells. Cancer Research. 73: 3679-3679. DOI: 10.1158/1538-7445.Am2013-3679 |
0.312 |
|
| 2013 |
Davidovics SA, Prizment A, Visvanathan K, Visvanathan K. Abstract 2525: Neutrophil count, cancer incidence and cancer mortality: disparate relationships by race. Cancer Research. 73: 2525-2525. DOI: 10.1158/1538-7445.Am2013-2525 |
0.501 |
|
| 2013 |
Murtola TJ, Visvanathan K, Artama M, Vainio H, Pukkala E. Abstract 136: Statins and breast cancer mortality. Cancer Research. 73: 136-136. DOI: 10.1158/1538-7445.Am2013-136 |
0.579 |
|
| 2013 |
Fackler M, Bujanda Z, Umbricht C, Teo W, Zhang Z, Visvanathan K, Jeter S, Argani P, Wang C, Ingle J, Boughey J, McGuire K, King T, Carey L, Cope L, et al. Abstract P2-06-01: cMethDNA is a quantitative circulating methylated DNA assay for detection of metastatic breast cancer and for monitoring response to therapy Cancer Research. 73. DOI: 10.1158/0008-5472.Sabcs13-P2-06-01 |
0.42 |
|
| 2013 |
Visvanathan K. Invited Commentary: Time to Move Breast Cancer Chemoprevention to Center Stage Current Obstetrics and Gynecology Reports. 2: 199-201. DOI: 10.1007/S13669-013-0064-5 |
0.578 |
|
| 2012 |
Kitahara CM, Wang SS, Melin BS, Wang Z, Braganza M, Inskip PD, Albanes D, Andersson U, Beane Freeman LE, Buring JE, Carreón T, Feychting M, Gapstur SM, Gaziano JM, Giles GG, ... ... Visvanathan K, et al. Association between adult height, genetic susceptibility and risk of glioma. International Journal of Epidemiology. 41: 1075-85. PMID 22933650 DOI: 10.1093/Ije/Dys114 |
0.31 |
|
| 2012 |
Nichols HB, Trentham-Dietz A, Newcomb PA, Titus LJ, Egan KM, Hampton JM, Visvanathan K. Postoophorectomy estrogen use and breast cancer risk. Obstetrics and Gynecology. 120: 27-36. PMID 22914389 DOI: 10.1097/Aog.0B013E31825A717B |
0.742 |
|
| 2012 |
Barron TI, Sharp L, Visvanathan K. Beta-adrenergic blocking drugs in breast cancer: a perspective review. Therapeutic Advances in Medical Oncology. 4: 113-25. PMID 22590485 DOI: 10.1177/1758834012439738 |
0.464 |
|
| 2012 |
Jacobs KB, Yeager M, Zhou W, Wacholder S, Wang Z, Rodriguez-Santiago B, Hutchinson A, Deng X, Liu C, Horner MJ, Cullen M, Epstein CG, Burdett L, Dean MC, Chatterjee N, ... ... Visvanathan K, et al. Detectable clonal mosaicism and its relationship to aging and cancer. Nature Genetics. 44: 651-8. PMID 22561519 DOI: 10.1038/Ng.2270 |
0.452 |
|
| 2012 |
McCarthy AM, Menke A, Ouyang P, Visvanathan K. Bilateral oophorectomy, body mass index, and mortality in U.S. women aged 40 years and older. Cancer Prevention Research (Philadelphia, Pa.). 5: 847-54. PMID 22556202 DOI: 10.1158/1940-6207.Capr-11-0430 |
0.61 |
|
| 2012 |
Zhang X, Spiegelman D, Baglietto L, Bernstein L, Boggs DA, van den Brandt PA, Buring JE, Gapstur SM, Giles GG, Giovannucci E, Goodman G, Hankinson SE, Helzlsouer KJ, Horn-Ross PL, Inoue M, ... ... Visvanathan K, et al. Carotenoid intakes and risk of breast cancer defined by estrogen receptor and progesterone receptor status: a pooled analysis of 18 prospective cohort studies. The American Journal of Clinical Nutrition. 95: 713-25. PMID 22277553 DOI: 10.3945/Ajcn.111.014415 |
0.483 |
|
| 2012 |
Yeh HC, Platz EA, Wang NY, Visvanathan K, Helzlsouer KJ, Brancati FL. A prospective study of the associations between treated diabetes and cancer outcomes. Diabetes Care. 35: 113-8. PMID 22100961 DOI: 10.2337/Dc11-0255 |
0.481 |
|
| 2012 |
Agyeman AS, Chaerkady R, Shaw PG, Davidson NE, Visvanathan K, Pandey A, Kensler TW. Transcriptomic and proteomic profiling of KEAP1 disrupted and sulforaphane-treated human breast epithelial cells reveals common expression profiles. Breast Cancer Research and Treatment. 132: 175-87. PMID 21597922 DOI: 10.1007/S10549-011-1536-9 |
0.34 |
|
| 2012 |
Barron TI, Sharp L, Bennett K, Visvanathan K. Aspirin use and mortality in women with stage I-III breast cancer: A population-based study. Journal of Clinical Oncology. 30: 521-521. DOI: 10.1200/Jco.2012.30.15_Suppl.521 |
0.424 |
|
| 2012 |
Barron TI, Sharp L, Visvanathan K. Beta-adrenergic blocking drugs in breast cancer: A perspective review Therapeutic Advances in Medical Oncology. 4: 113-125. DOI: 10.1177/1758834012439738 |
0.323 |
|
| 2012 |
Israel S, Warzecha H, Gross AL, Tatsas A, Lee A, May B, Axilbund J, Khouri N, Jacobs L, Armstrong D, Visvanathan K. Abstract 3568: Progression from benign breast disease to cancer in women with a family history of breast cancer Cancer Research. 72: 3568-3568. DOI: 10.1158/1538-7445.Am2012-3568 |
0.559 |
|
| 2012 |
Prizment AE, Folsom AR, Anderson KE, Visvanathan K, Joshu CE, Platz EA, Pankow JS. Abstract 1028: Association of plasma C-reactive protein (CRP) and CRP genetic risk score with cancer risk in the Atherosclerosis Risk in Communities (ARIC) study Cancer Research. 72: 1028-1028. DOI: 10.1158/1538-7445.Am2012-1028 |
0.535 |
|
| 2012 |
Karp J, Blackford A, Visvanathan K, Rugo H, Moy B, Goldstein L, Stockerl-Goldstein K, Neumayer L, Langbaum T, Hughes M, Weeks J, Wolff A. Abstract S3-5: Myelodysplatic syndrome and/or acute myelogenous leukemia (MDS and/or AML) after a breast cancer diagnosis: the National Comprehensive Cancer Network (NCCN) experience. Cancer Research. 72. DOI: 10.1158/0008-5472.Sabcs12-S3-5 |
0.561 |
|
| 2012 |
Khaliq W, Visvanathan K. Breast Cancer Chemoprevention: Current Approachesand Future Directions Current Obstetrics and Gynecology Reports. 1: 33-41. DOI: 10.1007/S13669-011-0005-0 |
0.587 |
|
| 2011 |
Konishi H, Mohseni M, Tamaki A, Garay JP, Croessmann S, Karnan S, Ota A, Wong HY, Konishi Y, Karakas B, Tahir K, Abukhdeir AM, Gustin JP, Cidado J, Wang GM, ... ... Visvanathan K, et al. Mutation of a single allele of the cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells. Proceedings of the National Academy of Sciences of the United States of America. 108: 17773-8. PMID 21987798 DOI: 10.1073/Pnas.1110969108 |
0.434 |
|
| 2011 |
Prizment AE, Anderson KE, Visvanathan K, Folsom AR. Inverse association of eosinophil count with colorectal cancer incidence: atherosclerosis risk in communities study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1861-4. PMID 21742945 DOI: 10.1158/1055-9965.Epi-11-0360 |
0.446 |
|
| 2011 |
Barron TI, Connolly RM, Sharp L, Bennett K, Visvanathan K. Beta blockers and breast cancer mortality: A population-based study Journal of Clinical Oncology. 29: 2635-2644. PMID 21632503 DOI: 10.1200/Jco.2010.33.5422 |
0.485 |
|
| 2011 |
Nichols HB, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L, Trentham-Dietz A. Bilateral oophorectomy in relation to risk of postmenopausal breast cancer: confounding by nonmalignant indications for surgery? American Journal of Epidemiology. 173: 1111-20. PMID 21430192 DOI: 10.1093/Aje/Kwq510 |
0.732 |
|
| 2011 |
Schonfeld SJ, Pfeiffer RM, Lacey JV, Berrington de González A, Doody MM, Greenlee RT, Park Y, Schairer C, Schatzkin A, Sigurdson AJ, Hartge P, Visvanathan K. Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study. American Journal of Epidemiology. 173: 509-17. PMID 21266505 DOI: 10.1093/Aje/Kwq404 |
0.77 |
|
| 2011 |
Prizment AE, Anderson KE, Visvanathan K, Folsom AR. Association of inflammatory markers with colorectal cancer incidence in the atherosclerosis risk in communities study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 297-307. PMID 21217085 DOI: 10.1158/1055-9965.Epi-10-1146 |
0.395 |
|
| 2011 |
Heaphy CM, Subhawong AP, Gross AL, Konishi Y, Kouprina N, Argani P, Visvanathan K, Meeker AK. Shorter telomeres in luminal B, HER-2 and triple-negative breast cancer subtypes. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 24: 194-200. PMID 21057458 DOI: 10.1038/Modpathol.2010.198 |
0.47 |
|
| 2011 |
Prizment AE, Anderson KE, Visvanathan K, Folsom AR. Abstract 4636: Inverse association of eosinophil count with colorectal cancer incidence in the Atherosclerosis Risk in Communities study Cancer Research. 71: 4636-4636. DOI: 10.1158/1538-7445.Am2011-4636 |
0.491 |
|
| 2011 |
Barron T, Sharp L, Bennett K, Visvanathan K. P1-08-18: Aspirin Exposure and Nodal Status at Diagnosis in Women with Stage I-III Breast Cancer. Cancer Research. 71. DOI: 10.1158/0008-5472.Sabcs11-P1-08-18 |
0.491 |
|
| 2010 |
Zheng W, Danforth KN, Tworoger SS, Goodman MT, Arslan AA, Patel AV, McCullough ML, Weinstein SJ, Kolonel LN, Purdue MP, Shu XO, Snyder K, Steplowski E, Visvanathan K, Yu K, et al. Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. American Journal of Epidemiology. 172: 70-80. PMID 20562186 DOI: 10.1093/Aje/Kwq118 |
0.424 |
|
| 2010 |
McCarthy AM, Dumanovsky T, Visvanathan K, Kahn AR, Schymura MJ. Racial/ethnic and socioeconomic disparities in mortality among women diagnosed with cervical cancer in New York City, 1995-2006. Cancer Causes & Control : Ccc. 21: 1645-55. PMID 20521091 DOI: 10.1007/S10552-010-9593-7 |
0.634 |
|
| 2010 |
Ueda SM, Yap KL, Davidson B, Tian Y, Murthy V, Wang TL, Visvanathan K, Kuhajda FP, Bristow RE, Zhang H, Shih IeM. Expression of Fatty Acid Synthase Depends on NAC1 and Is Associated with Recurrent Ovarian Serous Carcinomas. Journal of Oncology. 2010: 285191. PMID 20508725 DOI: 10.1155/2010/285191 |
0.337 |
|
| 2010 |
McCarthy AM, Visvanathan K. Breast cancer prognosis: weighing the evidence on weight and physical activity. Oncology (Williston Park, N.Y.). 24: 346-7, 350. PMID 20464846 |
0.616 |
|
| 2010 |
Olivo-Marston S, Graubard BI, Visvanathan K, Forman MR. Gender-specific differences in birthweight and the odds of puberty: NHANES III, 1988-94. Paediatric and Perinatal Epidemiology. 24: 222-31. PMID 20415751 DOI: 10.1111/J.1365-3016.2010.01097.X |
0.379 |
|
| 2010 |
Schonfeld SJ, Pee D, Greenlee RT, Hartge P, Lacey JV, Park Y, Schatzkin A, Visvanathan K, Pfeiffer RM. Effect of changing breast cancer incidence rates on the calibration of the Gail model. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2411-7. PMID 20368565 DOI: 10.1200/Jco.2009.25.2767 |
0.762 |
|
| 2010 |
Moorman PG, Iversen ES, Marcom PK, Marks JR, Wang F, Lee E, Ursin G, Rebbeck TR, Domchek SM, Arun B, Susswein L, Isaacs C, Garber JE, Visvanathan K, et al. Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Research and Treatment. 124: 441-51. PMID 20309627 DOI: 10.1007/S10549-010-0842-Y |
0.481 |
|
| 2010 |
Israel SA, Nassar H, Gross AL, Jacobs LK, Armstrong DK, Visvanathan K. Characterizing benign breast disease in women at high risk for breast cancer. Journal of Clinical Oncology. 28: 1506-1506. DOI: 10.1200/Jco.2010.28.15_Suppl.1506 |
0.589 |
|
| 2010 |
Bardia A, Huang P, Zhang Z, Sokoll L, Ingle JN, Carey LA, Lin NU, Nanda R, Visvanathan K, Wolff AC. Circulating tumor cell (CTC) and CA2729 as predictors of outcome in patients with metastatic breast cancer (MBC) in the prospective TBCRC 005 biomarker study. Journal of Clinical Oncology. 28: 1001-1001. DOI: 10.1200/Jco.2010.28.15_Suppl.1001 |
0.339 |
|
| 2010 |
Nichols HB, Visvanathan K, Newcomb PA, Hampton JM, Egan KM, Titus-Ernstoff L, Trentham-Dietz A. Abstract 876: Bilateral oophorectomy and breast cancer: Confounding by non-malignant indications for surgery Epidemiology. 70: 876-876. DOI: 10.1158/1538-7445.Am10-876 |
0.5 |
|
| 2010 |
Nour S, Mokri M, Torbagan S, Alavi A, Israel S, Atri M, Visvanathan K. Abstract 858: Prognostic markers associated with triple negative breast cancer in Iranian women: a prospective study Cancer Research. 70: 858-858. DOI: 10.1158/1538-7445.Am10-858 |
0.538 |
|
| 2010 |
Agyeman A, Shaw P, Chaerkady R, Tran Q, Sutter T, Pandey A, Visvanathan K, Davidson N, Kensler T. Abstract 5700: Establishing candidate biomarkers for the pharmacodynamic action of sulforaphane in the breast Cancer Research. 70: 5700-5700. DOI: 10.1158/1538-7445.Am10-5700 |
0.347 |
|
| 2010 |
McCarthy A, Nour S, Menke A, Visvanathan K. Abstract PD09-01: Oophorectomy, Adiposity, and Mortality in NHANES III, a Nationally Representative Sample Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-Pd09-01 |
0.644 |
|
| 2010 |
Barron T, Connolly R, Visvanathan K, Sharp L, Bennett K. Abstract P3-11-05: Association between Propanolol Use and Both Breast Cancer Incidence and Mortality Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-11-05 |
0.578 |
|
| 2010 |
Nichols H, Trentham-Dietz A, Newcomb P, Egan K, Titus-Ernstoff L, Hampton J, Visvanathan K. Abstract P3-11-04: Prediagnosis Hysterectomy and Estrogen Therapy in Relation to Mortality after Breast Cancer Cancer Research. 70. DOI: 10.1158/0008-5472.Sabcs10-P3-11-04 |
0.727 |
|
| 2010 |
Visvanathan K, Lippman SM, Hurley P, Temin S. Corrigendum to "American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction" [Gynecol. Oncol. 115 (2009) 132-134] (DOI:10.1016/j.ygyno.2009.06.006) Gynecologic Oncology. 116: 592. DOI: 10.1016/J.Ygyno.2009.12.019 |
0.449 |
|
| 2009 |
Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, et al. American Society of Clinical Oncology Clinical Practice Guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction Journal of Oncology Practice. 5: 196-199. PMID 29452019 DOI: 10.1200/Jop.0948502 |
0.452 |
|
| 2009 |
Wang L, Brune KA, Visvanathan K, Laheru D, Herman J, Wolfgang C, Schulick R, Cameron JL, Goggins M, Hruban RH, Klein AP. Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 2829-34. PMID 19843679 DOI: 10.1158/1055-9965.Epi-09-0557 |
0.504 |
|
| 2009 |
Tsilidis KK, Helzlsouer KJ, Smith MW, Grinberg V, Hoffman-Bolton J, Clipp SL, Visvanathan K, Platz EA. Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer Cancer Causes and Control. 20: 1739-1751. PMID 19760027 DOI: 10.1007/S10552-009-9427-7 |
0.342 |
|
| 2009 |
Visvanathan K, Lippman SM, Hurley P, Temin S. American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. Gynecologic Oncology. 115: 132-4. PMID 19716939 DOI: 10.1016/j.ygyno.2009.06.006 |
0.345 |
|
| 2009 |
Visvanathan K, Chlebowski RT, Hurley P, Col NF, Ropka M, Collyar D, Morrow M, Runowicz C, Pritchard KI, Hagerty K, Arun B, Garber J, Vogel VG, Wade JL, Brown P, et al. American society of clinical oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 3235-58. PMID 19470930 DOI: 10.1200/Jco.2008.20.5179 |
0.487 |
|
| 2009 |
Nassar H, Sharafaldeen B, Visvanathan K, Visscher D. Ductal carcinoma in situ in African American versus Caucasian American women: analysis of clinicopathologic features and outcome. Cancer. 115: 3181-8. PMID 19452544 DOI: 10.1002/Cncr.24376 |
0.346 |
|
| 2009 |
Bergeron-Sawitzke J, Gold B, Olsh A, Schlotterbeck S, Lemon K, Visvanathan K, Allikmets R, Dean M. Multilocus analysis of age-related macular degeneration. European Journal of Human Genetics : Ejhg. 17: 1190-9. PMID 19259132 DOI: 10.1038/Ejhg.2009.23 |
0.302 |
|
| 2009 |
Berrington de Gonzalez A, Berg CD, Visvanathan K, Robson M. Estimated risk of radiation-induced breast cancer from mammographic screening for young BRCA mutation carriers. Journal of the National Cancer Institute. 101: 205-9. PMID 19176458 DOI: 10.1093/Jnci/Djn440 |
0.496 |
|
| 2009 |
Jorgensen TJ, Helzlsouer KJ, Clipp SC, Bolton JH, Crum RM, Visvanathan K. DNA repair gene variants associated with benign breast disease in high cancer risk women Cancer Epidemiology Biomarkers and Prevention. 18: 346-350. PMID 19124519 DOI: 10.1158/1055-9965.Epi-08-0659 |
0.548 |
|
| 2008 |
Bao T, Shahverdi K, Blackford AL, Prowell T, Jeter SC, Powers P, Wright L, Snyder CF, Stearns V, Visvanathan K. Quality of life (QOL) changes in breast cancer patients participating in an anastrozole secondary prevention trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 1515. PMID 27948356 DOI: 10.1200/Jco.2008.26.15_Suppl.1515 |
0.443 |
|
| 2008 |
van Bemmel DM, Visvanathan K, Beane Freeman LE, Coble J, Hoppin JA, Alavanja MC. S-ethyl-N,N-dipropylthiocarbamate exposure and cancer incidence among male pesticide applicators in the agricultural health study: a prospective cohort. Environmental Health Perspectives. 116: 1541-6. PMID 19057708 DOI: 10.1289/Ehp.11371 |
0.347 |
|
| 2008 |
Bransfield LA, Rennie A, Visvanathan K, Odwin SA, Kensler TW, Yager JD, Friesen MD, Groopman JD. Formation of two novel estrogen guanine adducts and HPLC/MS detection of 4-hydroxyestradiol-N7-guanine in human urine. Chemical Research in Toxicology. 21: 1622-30. PMID 18582124 DOI: 10.1021/Tx800145W |
0.305 |
|
| 2008 |
Kurman RJ, Visvanathan K, Roden R, Wu TC, Shih IeM. Early detection and treatment of ovarian cancer: shifting from early stage to minimal volume of disease based on a new model of carcinogenesis. American Journal of Obstetrics and Gynecology. 198: 351-6. PMID 18395030 DOI: 10.1016/J.Ajog.2008.01.005 |
0.355 |
|
| 2008 |
Sprenger A, Gross A, Axilbund J, Helzlsouer K, Armstrong D, May B, Visvanathan K. Abstract B25: Information on perceived breast cancer risk may help tailor risk assessment among high risk women Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-B25 |
0.551 |
|
| 2008 |
Schonfeld S, Pfeiffer R, Lacey J, Hartge P, Doody M, Greenlee R, Park Y, Schairer C, Schatzkin A, Sigurdson A, Visvanathan K. Abstract A79: Hormonal factors and breast cancer risk in nulliparous women Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-A79 |
0.609 |
|
| 2008 |
Jorgensen T, Helzlsouer K, Hoffman S, Hoffman-Bolton J, Crum R, Visvanathan K. Abstract A75: DNA repair genotypes associated with benign breast disease in women at high breast cancer risk Cancer Prevention Research. 1. DOI: 10.1158/1940-6207.Prev-08-A75 |
0.565 |
|
| 2007 |
Matsubayashi H, Infante JR, Winter J, Klein AP, Schulick R, Hruban R, Visvanathan K, Goggins M. Tumor COX-2 expression and prognosis of patients with resectable pancreatic cancer. Cancer Biology & Therapy. 6: 1569-75. PMID 18000398 DOI: 10.4161/Cbt.6.10.4711 |
0.407 |
|
| 2007 |
Visvanathan K, Santor D, Ali SZ, Brewster A, Arnold A, Armstrong DK, Davidson NE, Helzlsouer KJ. The reliability of nipple aspirate and ductal lavage in women at increased risk for breast cancer - A potential tool for breast cancer risk assessment and biomarker evaluation Cancer Epidemiology Biomarkers and Prevention. 16: 950-955. PMID 17507621 DOI: 10.1158/1055-9965.Epi-06-0974 |
0.558 |
|
| 2007 |
Cornblatt BS, Ye L, Dinkova-Kostova AT, Erb M, Fahey JW, Singh NK, Chen MSA, Stierer T, Garrett-Mayer E, Argani P, Davidson NE, Talalay P, Kensler TW, Visvanathan K. Preclinical and clinical evaluation of sulforaphane for chemoprevention in the breast Carcinogenesis. 28: 1485-1490. PMID 17347138 DOI: 10.1093/Carcin/Bgm049 |
0.429 |
|
| 2007 |
Gallicchio L, Visvanathan K, Burke A, Hoffman SC, Helzlsouer KJ. Nonsteroidal anti-inflammatory drugs and the risk of developing breast cancer in a population-based prospective cohort study in Washington County, MD. International Journal of Cancer. Journal International Du Cancer. 121: 211-15. PMID 17330846 DOI: 10.1002/Ijc.22656 |
0.604 |
|
| 2007 |
Visvanathan K, Crum RM, Strickland PT, You X, Ruczinski I, Berndt SI, Alberg AJ, Hoffman SC, Comstock GW, Bell DA, Helzlsouer KJ. Alcohol dehydrogenase genetic polymorphisms, low-to-moderate alcohol consumption, and risk of breast cancer. Alcoholism, Clinical and Experimental Research. 31: 467-76. PMID 17295732 DOI: 10.1111/J.1530-0277.2006.00334.X |
0.44 |
|
| 2007 |
Jorgensen TJ, Visvanathan K, Ruczinski I, Thuita L, Hoffman S, Helzlsouer KJ. Breast cancer risk is not associated with polymorphic forms of xeroderma pigmentosum genes in a cohort of women from Washington County, Maryland Breast Cancer Research and Treatment. 101: 65-71. PMID 16823510 DOI: 10.1007/S10549-006-9263-3 |
0.554 |
|
| 2006 |
Platz EA, Leitzmann MF, Visvanathan K, Rimm EB, Stampfer MJ, Willett WC, Giovannucci E. Statin drugs and risk of advanced prostate cancer. Journal of the National Cancer Institute. 98: 1819-25. PMID 17179483 DOI: 10.1093/Jnci/Djj499 |
0.449 |
|
| 2006 |
Visvanathan K, Sukumar S, Davidson NE. Epigenetic biomarkers and breast cancer: cause for optimism. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 6591-3. PMID 17121875 DOI: 10.1158/1078-0432.Ccr-06-2001 |
0.398 |
|
| 2005 |
Visvanathan K, Santor D, Ali S, Brewster A, Arnold A, Armstrong D, Helzlsouer K. The reliability of ductal lavage in women at high risk for breast cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 1001. PMID 27944893 DOI: 10.1200/Jco.2005.23.16_Suppl.1001 |
0.558 |
|
| 2005 |
Gallicchio L, Visvanathan K, Miller SR, Babus J, Lewis LM, Zacur H, Flaws JA. Body mass, estrogen levels, and hot flashes in midlife women. American Journal of Obstetrics and Gynecology. 193: 1353-60. PMID 16202725 DOI: 10.1016/J.Ajog.2005.04.001 |
0.318 |
|
| 2004 |
O'Brien TG, Guo Y, Visvanathan K, Sciulli J, McLaine M, Helzlsouer KJ, Watkins-Bruner D. Differences in ornithine decarboxylase and androgen receptor allele frequences among ethnic groups Molecular Carcinogenesis. 41: 120-123. PMID 15378650 DOI: 10.1002/Mc.20047 |
0.348 |
|
| 2004 |
Platz EA, De Marzo AM, Erlinger TP, Rifai N, Visvanathan K, Hoffman SC, Helzlsouer KJ. No association between pre-diagnostic plasma C-reactive protein concentration and subsequent prostate cancer. The Prostate. 59: 393-400. PMID 15065087 DOI: 10.1002/Pros.10368 |
0.35 |
|
| 2004 |
Visvanathan K, Helzlsouer KJ, Boorman DW, Strickland PT, Hoffman SC, Comstock GW, O'Brien TG, Guo Y. Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk. The Journal of Urology. 171: 652-5. PMID 14713779 DOI: 10.1097/01.Ju.0000108384.74718.73 |
0.332 |
|
| 2003 |
Davidson NE, Visvanathan K, Emens L. New findings about endocrine therapy for breast cancer. Breast (Edinburgh, Scotland). 12: 368-72. PMID 14659107 DOI: 10.1016/S0960-9776(03)00138-3 |
0.465 |
|
| 2003 |
Visvanathan K, Davidson NE. Aromatase inhibitors as adjuvant therapy in breast cancer. Oncology (Williston Park, N.Y.). 17: 335-42, 347; discuss. PMID 12661266 |
0.415 |
|
| 1998 |
Alberg AJ, Visvanathan K, Helzlsouer KJ. Epidemiology, prevention, and early detection of breast cancer Current Opinion in Oncology. 10: 492-497. PMID 9818226 |
0.511 |
|
| Show low-probability matches. |